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Abstract 
 
Skeletal muscle can adapt its structure to cope with the mechanical and metabolic 
stresses placed on it by various amounts and patterns of human movement. The release 
of calcium into the cytoplasm of muscle fibres is thought to have an important role in 
these adaptations, yet the calcium-dependent signalling pathways involved haven’t been 
fully defined. Calcium/calmodulin-dependent protein kinase II (CaMKII) has been 
presumed to drive mitochondrial biogenesis in skeletal muscle, but this has not been 
investigated in vivo.The experiments in this thesis aimed to address how CaMKII is 
activated in response to electrical stimulation of skeletal muscle and how CaMKII 
affects the muscle phenotype. A rat model was used for two main reasons: 1) it allowed 
for imposing well-defined stimulation patterns onto phenotypically homogenous muscle 
fibre populations under controlled conditions in situ, and investigating the molecular 
response to these stimulation patterns, and 2) it allowed for manipulation of CaMKII 
signalling in muscle fibres in vivo through the use of electro-assisted somatic gene 
transfer.It was hypothesised that CaMKII would be activated in a muscle and 
recruitment pattern specific manner. Furthermore, it was hypothesised that CaMKII 
overexpression would increase the expression of mitochondrial markers. In chapter 2, 
the effect of recruitment frequency on CaMKII phosphorylation in slow-twitch m. 
soleus and fast-twitch m. gastrocnemius medialis is investigated. Furthermore, the time 
course of CaMKII phosphorylation after muscle stimulation is studied. Chapter 3 
presents a study into the effects of in vivo CaMKII overexpression in m. soleus and m. 
gastrocnemius on mitochondrial gene expression and muscle contractile function. The 
effects of CaMKII overexpression on skeletal alpha-actin transcription are presented in 
chapter 4. In chapter 5, a mathematical model of CaMKII activation in sarcomeres is 
described, and used to investigate the effects of CaMKII overexpression on calcium 
handling and on contractile properties of a muscle fibre. It was concluded that CaMKII 
is activated by very brief stimulation in a recruitment frequency-independent manner, 
and that increased CaMKII protein levels increase SERCA expression, but not 
mitochondrial gene expression.  
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Movement of the human body occurs by activating skeletal muscles, which exert force 
that is transmitted to the skeleton via tendons and other connective tissue structures. 
Sufficient muscle mass is needed to maintain mobility throughout the human life span, 
but is also important for whole body metabolic function as muscle provides a reservoir 
of amino acids, acts as an important glucose storage site, and is important in controlling 
resting metabolic rates of the body (Wolfe, 2006). Mitochondrial abundance in muscle 
is important for fatigue resistance and is essential for the body’s capacity to use fatty 
acids as a source of energy (Hood, 2001). Maintaining good muscle health is therefore 
critical to maintaining overall health. 
Skeletal muscle is a very plastic tissue which can adapt its structure to cope 
with the mechanical and metabolic stresses placed on it by various amounts and patterns 
of human movement (Fluck and Hoppeler, 2003). Important factors that regulate 
adaptations of muscle must be present in its muscle fibres, as it has been demonstrated 
that while active muscles adapt to a training program, non-active muscles in the same 
body do not adapt or adapt to a much lesser extent (Saltin et al., 1976). Knowledge of 
these factors underlying muscle adaptation might allow for the characterisation of the 
intramuscular response to a single exercise bout, and subsequent tailoring of training 
protocols to the needs of the individual, the monitoring of training by using the 
regulatory molecules as ‘progress markers’, and the development of gene and/or 
pharmacological therapies that selectively activate the signalling pathways which are 
important for skeletal muscle adaptation. This would provide the means to mimic some 
of the health benefits of exercise while eliminating the need for the actual exercise 
session. This could be of particular relevance to those who cannot exercise due to 
illnesses such as cardiovascular diseases and muscular dystrophies.  
The aim of this thesis is to investigate the role of calcium/calmodulin-
dependent protein kinase II (CaMKII), which is hypothesised to regulate adaptation of 
skeletal muscle to exercise. This introductory chapter will discuss muscle plasticity and 
why it is of interest to investigate the role of CaMKII in skeletal muscle.      
 
11 
 
Skeletal muscle phenotype and function  
Skeletal muscle fibres are elongated multi-nucleated cells which consist of myofibrils 
containing highly arranged contractile protein filaments of which actin and myosin are 
the important ones. Contraction is initiated upon depolarisation of the plasma membrane 
of the muscle fibre which triggers a rise in cytoplasmic calcium concentration. This is 
mediated by the release of calcium from the sarcoplasmic reticulum (SR) through the 
ryanodine receptor (RyR). The SR is an intracellular calcium store that envelops the 
myofibrils. Calcium is continuously removed from the cytoplasm into the SR by the 
sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCA). This ensures that the intracellular 
levels of calcium are only significantly elevated when the muscle is recruited to 
contract. Cytoplasmic calcium binds to troponin C, which is part of a protein complex 
that blocks binding sites for myosin heads on the actin filaments. Upon binding of 
calcium to troponin C, the binding sites on actin are exposed and myosin heads can 
undergo cycles of attachment to actin, bending – thereby producing force – and 
detachment. The maximum force a muscle fibre can produce is determined by the 
number of contractile proteins arranged in parallel. All other things being equal, more 
parallel contractile filaments means a greater cross-sectional area of the fibre and 
greater maximal force. 
  As detachment of the myosin heads from the actin filaments costs energy in 
the form of ATP, it is essential that a sufficient supply of ATP to the myofilaments is 
maintained in order for muscle contraction to continue. During prolonged contraction, 
this energy is provided through anaerobic glycolysis and aerobic metabolism of 
carbohydrates and lipids. Key to this process is the generation of reduction equivalents 
NADH and FADH in the citric acid cycle, and the subsequent generation of ATP via 
oxidative phosphorylation, in the mitochondria. Mitochondrial density therefore 
determines the capacity for oxidative metabolism, and is an important factor in 
determining the fatigue resistance of skeletal muscles.  
Although there is a large heterogeneity in the skeletal muscle phenotype, a key 
distinction can be made between slow-twitch and fast-twitch fibres, which express type 
I and type II myosin heavy chain, respectively (Schiaffino and Reggiani, 2011). Fast-
twitch fibres display higher myosin ATPase activity, which allows for a higher 
maximum contractile speed (Bottinelli et al., 1996). Human skeletal muscles are made 
12 
 
up of a mixture of these two main fibre types, and a phenotypic switch from slow- to 
fast-twitch or vice versa is thought to require extreme changes in muscle activity in 
humans (Harridge, 2007). Therefore, when studying the mechanisms underlying skeletal 
muscle adaptation to exercise, it will be important to consider the influence of fibre type 
on the adaptation process.  
 
Phenotypic adaptations of skeletal muscle 
Phenotypic adaptations in response to altered muscle recruitment allow the muscle to 
optimise its functional capacity to the demands that are being placed on it. Cross-
innervation experiments suggested that the nerve supplying the muscle affects muscle 
phenotype (Buller et al., 1960). It was later shown that specific nerve activity patterns 
could transform fast-twitch fibres into slow-twitch fibres and vice versa (Salmons and 
Vrbova, 1969) and that muscle activity, rather than substances released from the nerve 
ending, was important for changes in muscle fibre type (Lomo et al., 1974). Similarly, 
mitochondrial enzyme activity was shown to increase in skeletal muscle after training in 
rats (Holloszy, 1967) and humans (Gollnick et al., 1973), and the changes in enzyme 
activities were dependent on the nerve activity pattern (Golisch et al., 1970). These 
studies suggest the existence of local mechanisms present within skeletal muscles that 
connect recruitment-related stimuli with cellular adaptation. Experiments which 
demonstrate that isolated single fibres subjected to chronic electrical stimulation in 
culture display changes in expression of contractile proteins support that these 
mechanisms are, at least in part, present in the skeletal muscle fibres themselves (Liu 
and Schneider, 1998, Mu et al., 2007).   
 
The mechanisms by which muscle recruitment controls phenotypic changes in skeletal 
muscle are still unclear. Trained athletes have higher baseline levels of metabolic gene 
transcripts in skeletal muscle (Puntschart et al., 1995, Schmitt et al., 2003), which might 
underlie their superior muscle endurance. Expression of fos and jun genes, which are 
typically expressed very rapidly in response to various extra- and intracellular stimuli, is 
transiently increased after a bout of exercise (Puntschart et al., 1998), and the 
transcription of genes involved in fat/glucose metabolism is also activated within the 
first four hours after an exercise bout (Pilegaard et al., 2000, Hildebrandt et al., 2003). It 
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has been demonstrated that after an exercise session changes in the expression of many 
genes in muscle occur during the first hours of recovery (Pilegaard et al., 2000, Tunstall 
et al., 2002, Pilegaard et al., 2003, Mahoney et al., 2005, Schmutz et al., 2006, Mahoney 
et al., 2008). Increased mRNA levels provide increased template for protein synthesis 
by translation. Therefore, the cumulative effects of these changes in transcript levels 
might underlie structural changes in muscle protein expression and improved muscle 
function (Fluck, 2006). 
 
It has become clear that the intracellular homeostatic disturbances that occur during 
muscle contraction are signals that activate signalling pathways which regulate gene 
expression (Fluck and Hoppeler, 2003). Figure 1 provides an overview of some of these 
pathways in skeletal muscle, and shows how CaMKII might be linked to changes in 
gene expression.   The increase in intracellular calcium concentration during muscle 
contraction has been linked to multiple adaptive processes, which will be discussed in 
the next section. 
 
The role of calcium in muscle adaptations 
Intracellular calcium release is directly related to the degree of activation of a muscle 
fibre. This makes calcium an excellent candidate to relay muscle use-related 
information to signalling molecules and downstream activation of pathways that 
coordinate changes in gene expression and regulate muscle remodelling. Indeed, it has 
been shown that changes in intracellular calcium concentration can induce various 
adaptations of skeletal muscle. This was first demonstrated in cultures of muscle 
precursor cells, where an increase in the intracellular cytoplasmic calcium concentration 
by addition of a calcium ionophore (a compound that facilitates the transport of calcium 
across the plasma membrane) resulted in increased expression of type I myosin heavy 
chain and mitochondrial enzyme citrate synthase, and decreased expression of type II 
myosin heavy chain and glycolytic enzyme lactate dehydrogenase (Kubis et al., 1997). 
Also, in whole rat muscles ex vivo, chronically increasing calcium levels increased 
transcript levels of genes encoding mitochondrial enzymes (Wright et al., 2007). 
Finally, mice exposed to cold displayed increased basal levels of calcium and increased 
citrate synthase activity in skeletal muscles (Bruton et al., 2010). However, in all of 
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these models the calcium concentration was chronically increased, which is very 
dissimilar to the transient increases in calcium concentration induced by muscle 
recruitment in vivo. In mice that lacked the gene for parvalbumin, an important calcium 
buffer in fast-twitch muscle, the duration of electrical stimulation-induced calcium 
transients, but not basal calcium concentration, was increased, as was the mitochondrial 
density (Chen et al., 2001, Racay et al., 2006). Conversely, slow-twitch muscles of 
parvalbumin-overexpressing mice had lower mitochondrial enzyme activity (Chin et al., 
2003). Thus, the levels of mitochondrial enzymes can also be affected by more subtle 
perturbations of calcium levels. However, the amplitude of calcium transients in mice 
which lack calsequestrin, a calcium buffer located in the SR, in their skeletal muscles 
were reduced, and yet the fast-twitch m.extensor digitorum longus of these animals had 
a higher mitochondrial density compared to wild-type controls (Paolini et al., 2007). 
Note that conclusions drawn from studies using transgenic mice models may be 
influenced by compensatory adaptations during development. Taken together, these 
results suggest that the contraction-induced increase in calcium concentration in muscle 
fibres leads to an increase in mitochondrial biogenesis.  
 
This raises the question of how the increased calcium concentration is transduced into 
changes in gene expression. Various transcription factors that have been demonstrated 
to activate the expression of genes involved in muscle remodelling are sensitive to 
calcium-dependent signalling pathways (Bassel-Duby and Olson, 2006). The two most 
studied calcium transducers in skeletal muscle are CaMKII and calcineurin, a 
calcium/calmodulin-dependent protein phosphatase. Current literature suggests that 
calcineurin is sufficient and necessary to induce expression of slow fibre type-related 
myofibrillar proteins (Chin et al., 1998, Naya et al., 2000, Serrano et al., 2001, Parsons 
et al., 2004). In addition, lifelong expression of constitutively active calcineurin is 
sufficient to increase mitochondrial gene expression and maximal mitochondrial 
respiration (Long et al., 2007, Jiang et al., 2010). However, inhibiting calcineurin in 
vivo with cyclosporin did not prevent increased mitochondrial gene expression in 
response to swimming exercise in rats (Garcia-Roves et al., 2006). This suggests that 
calcineurin is not required for increased mitochondrial biogenesis in response to 
exercise, and other pathways must be involved. 
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CaMKII as a calcium-dependent regulator of skeletal muscle 
phenotype 
A possible candidate to relay calcium concentration changes to multiple adaptation 
processes is calcium/calmodulin-dependent protein kinase II (CaMKII), which is the 
focus of investigation in this thesis. CaMKII is a protein serine/threonine kinase, which 
has first been discovered in neuronal membranes (Schulman and Greengard, 1978), and 
is thought to be involved in the formation of memory (Lisman et al., 2002). Four 
CaMKII genes are present in the human genome, encoding alpha, beta, gamma and 
delta isoforms of CaMKII. All isoforms have multiple splice variants, which results in at 
least 38 different variants being expressed in a cell-specific pattern (Tombes et al., 
2003). All four CaMKII genes contain a N-terminal kinase domain, a C-terminal 
association domain and a variable autoregulatory region  (Hudmon and Schulman, 
2002) and form dodecamers with very similar structures, but slightly different 
sensitivities for calcium-bound calmodulin (Gaertner et al., 2004).  
 
CaMKII is part of a larger protein family of calcium/calmodulin-dependent protein 
kinases, of which CaMKI, CaMKIV and calcium/calmodulin-dependent kinase kinase 
(CaMKK) have multiple substrates. The CaMK family of genes also includes glycogen 
phosphorylase kinase, myosin light chain kinase and eukaryotic elongation factor 2 
kinase (also known as CaMKIII), which have single substrates.  
CaMKI seems to be expressed in mouse skeletal muscle, but not in human 
skeletal muscle (Rose et al., 2006, Witczak et al., 2007). CaMKII is expressed in rodent 
and human skeletal muscle (Woodgett et al., 1982, Rose et al., 2006). CaMKIV is 
expressed in neither human, nor rodent skeletal muscle (Akimoto et al., 2004, Rose et 
al., 2006). This is relevant, as inferences have been made about the function of CaMKII 
based on studies into the effects of other members of the CaMK family. However, 
CaMKII is the only multifunctional CaMK expressed in human skeletal muscle (Rose et 
al., 2006). CaMKK alpha, which acts upstream of CaMK’s, is also expressed in human 
skeletal muscle (Rose et al., 2006). This kinase phosphorylates CaMKI and IV, but not 
CaMKII (Tokumitsu et al., 1995), and it is therefore possible that CaMKK alpha is a 
part of a separate calcium/calmodulin-dependent pathway in skeletal muscle.  
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The role of CaMKII in structural adaptation of skeletal muscle to exercise is currently 
unclear. CaMKII is activated during cycling exercise (Rose et al., 2006), and this 
activation depends on cycling intensity (Egan et al., 2010). However, it is not known 
which intramuscular factors related to cycling intensity are important for this regulation. 
Basal CaMKII activity was increased in rooster skeletal muscle by overloading (Fluck 
et al., 2000b) and in human m. vastus lateralis by cycling exercise (Rose et al., 2007b), 
suggesting it may be involved in the adaptation to these protocols.  
CaMK's have been proposed to regulate a number of biological processes in skeletal 
muscle (Fig. 1). Transgenic mice overexpressing a constitutively active mutant of 
CaMKIV have increased mitochondrial density, which was thought to be caused by 
increased expression of transcription co-factor peroxisome proliferator-activated 
receptor ɣ coactivator-1 (PGC-1) expression (Wu et al., 2002). Overexpression of PGC-
1 increased mitochondrial biogenesis in cultured myotubes (Wu et al., 1999). Many 
studies have demonstrated that CaMK's can regulate the activity of various transcription 
factors involved in the regulation of PGC-1 expression, usually in cultured myoblasts 
(Lu et al., 2000b, McKinsey et al., 2000a, McKinsey et al., 2000b, Wu et al., 2000, 
Handschin et al., 2003). The picture emerging from these studies is that CaMK's 
regulate gene expression in skeletal muscle cells by a general mechanism involving the 
phosphorylation of histone deacetylases (HDACs; Fig. 1). HDACs bind to transcription 
factor, myocyte enhancer factor 2 (MEF2), and inhibit its transcriptional activity. Upon 
phosphorylation by CaMK, HDAC is removed from the cell nucleus and MEF2 can 
bind to the PGC1 promoter and activate PGC1 transcription. These studies suggest that 
CaMK activates mitochondrial biogenesis in skeletal muscle. However, these studies 
have used overexpression of constitutively active mutants of CaMKI or CaMKIV, 
neither of which is expressed in human skeletal muscle (Rose et al., 2006). The question 
remains whether CaMKII also regulates these factors. It has been demonstrated in 
cardiac myocytes that CaMKII can phosphorylate HDAC4, thereby inducing its export 
from the nucleus (Backs et al., 2006), and activating a MEF2-dependent reporter gene 
(Zhang et al., 2007), but in skeletal muscle this information is still missing.   
CaMKII isolated from chicken skeletal muscle phosphorylates serum response 
factor (SRF) (Fluck et al., 2000a), a transcription factor which is essential for skeletal 
alpha-actin gene transcription during skeletal muscle development (Croissant et al., 
1996). This indicates that CaMKII may also be involved in the regulation of skeletal 
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alpha-actin expression (Fig. 1), which is increased in response to stretch overloading of 
chicken skeletal muscle (Gregory et al., 1990). Furthermore, CaMKIV activates SRF-
dependent transcriptional activity by removing HDAC4-dependent SRF inhibition in 
cardiomyocytes (Davis et al., 2003), indicating there may be another mechanism 
whereby CaMK’s regulate gene transcription in skeletal muscle through HDACs. 
 
The involvement of CaMKII in regulating gene expression in skeletal muscle and 
adaptation of its phenotype has also been suggested by studies using pharmacological 
CaMK inhibitors. Electrical  stimulation of cultured adult mouse muscle fibres results in 
export of HDAC4 from the nucleus and activation of a MEF2-dependent reporter gene, 
and these effects are blocked by the calmodulin-competitive inhibitor KN62 (Liu et al., 
2005). KN93, another calmodulin-competitive CaMK inhibitor, inhibits the expression 
of slow-fibre type genes in cultured adult mouse muscle fibres (Mu et al., 2007). In rats, 
KN93 blocked the swimming exercise-induced binding of MEF2 to the glucose 
transporter 4 (GLUT4) promoter (Smith et al., 2008). These studies suggest that 
CaMK's are involved in the regulation of MEF2 activity and gene expression in whole 
muscle. However, inhibition of calcium-induced expression of mitochondrial genes by 
KN93 has only been demonstrated in cultured myotubes (Ojuka et al., 2003). 
Furthermore, the KN62/KN93 inhibitors suppress the activity of all CaMK's (Wayman 
et al., 2008) and have effects on calcium/calmodulin-independent enzymes and ion 
channels as well (Davies et al., 2000, Gao et al., 2006, Ledoux et al., 1999). Therefore, 
it is not certain whether the observed effects in these studies can be ascribed to 
inhibition of CaMKII only.  
 
Finally, there is evidence that CaMKII has acute effects on muscle function. In mouse 
skeletal muscle, its inhibition has been shown to decrease calcium release from the SR 
(Tavi et al., 2003) and glucose uptake during muscle contraction (Witczak et al., 2010). 
 
In conclusion, although it has recently been claimed that "there is overwhelming 
experimental support for CaN and CaMKII being capable of inducing major changes in 
muscle fibre properties" (Tavi and Westerblad, 2011), the above review of the current 
literature indicates that although there are suggestions that CaMKII is a key regulator of 
18 
 
the expression of genes involved in muscle fibre adaptations in vivo, this has not been 
tested yet by modifying CaMKII isoforms in vivo. 
 
 
  
Figure 1: Potential intracellular signalling pathways involved in skeletal muscle adaptation 
to exercise 
Diagram showing how CaMKII may affect muscle phenotype by altering gene expression. In 
addition, CaMKII is thought to stimulate calcium release from, and uptake into, the sarcoplasmic 
reticulum. A few other pathways thought to be important for skeletal muscle adaptation are also 
shown. Note that not all factors currently believed to regulate muscle adaptation are included in 
this overview, and that the scientific evidence for the pathways shown here is incomplete. Recent 
reviews on the topic are available (Gundersen, 2011). Abbreviations: RyR: ryanodine receptor; 
SERCA: sarco/endoplasmic reticulum Ca2+-ATPase; CaMKII: calcium/calmodulin-dependent 
protein kinase II; CaM: calmodulin; CaN: calcineurin; AMPK: 5’-AMP-activated protein kinase; 
p38 MAPK: p38 Mitogen-activated protein kinase; HDAC: histone deacetylase; MEF: myocyte 
enhancer factor; CREB: cAMP-reactive element binding protein; SRF: serum response factor; Sk. 
α-actin: skeletal alpha-actin; NFAT: nuclear factor of activated t-cells; PGC-1: peroxisome 
proliferator-activated receptor gamma coactivator 1; NRF1/2: nuclear respiratory factor 1 & 
nuclear respiratory factor 2.     
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Aims and thesis outline 
The gap in our current understanding of CaMKII function in skeletal muscle is how its 
activity is regulated in skeletal muscle by the recruitment pattern, and what the effects 
of CaMKII are on skeletal muscle function in vivo, in slow- and fast-twitch muscle. The 
experiments in this thesis aim to address this gap in knowledge. A rat model is used, 
because it allows for imposing well-defined stimulation patterns onto phenotypically 
homogenous muscle fibre populations under controlled conditions in situ, and 
investigating the molecular response to these stimulation patterns. Furthermore, it 
allows for manipulation of CaMKII signalling in muscle fibres in vivo through the use 
of electro-assisted somatic gene transfer. 
  In chapter 2, the effect of recruitment frequency on CaMKII phosphorylation 
in slow-twitch m. soleus and fast-twitch m. gastrocnemius medialis is investigated. 
Furthermore, the time course of CaMKII phosphorylation after muscle stimulation is 
studied. Chapter 3 presents a study into the effects of in vivo CaMKII overexpression 
in m. soleus and m. gastrocnemius on mitochondrial gene expression and muscle 
contractile function. The effects of CaMKII overexpression on skeletal alpha-actin 
transcription are presented in chapter 4. Experimental control is inherently limited in 
biological experiments and therefore it can be difficult to identity cause and effect. 
Mathematical modelling provides perfect control of system parameters, which allows 
dissecting biological mechanisms and generating new hypotheses. In chapter 5, a 
mathematical model of CaMKII activation in sarcomeres is described, and used to 
investigate the effects of CaMKII overexpression on calcium handling and on 
contractile properties of a muscle fibre. The thesis is concluded with a general 
discussion in chapter 6 of the implications of the results for our understanding of 
CaMKII function in skeletal muscle. 
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Abstract 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is activated in skeletal 
muscle during exercise, but how this activity is regulated by the pattern of muscle 
recruitment is unknown. As this likely has implications for its function, we investigated 
if CaMKII activation depends on recruitment frequency and what the time course of its 
activity is after muscle stimulation, using in situ stimulation of adult rat skeletal muscle. 
Protein levels of total CaMKII and phospho
Thr287
-CaMKII were measured for the βM, δA 
& δD/γB isoforms. In the first experiment, m. soleus (SOL) and m. gastrocnemius 
medialis (GM) were stimulated at active slack length with 100 electrical impulses at 10 
or 150 Hz. This protocol increased phospho
Thr287
-CaMKII of δA (p=0.05) and δD/γB 
(p=0.05) isoforms in red GM (GMR), δA isoform (p=0.043) in white GM (GMW), but 
none of the isoforms in SOL. There was no effect of frequency on the level of 
phospho
Thr287
-CaMKII. In GMW, we observed a decrease in total CaMKII after 150 Hz 
stimulation in two isoforms (βM: p=0.03, δD/γB: p=0.03). In the second experiment, we 
sampled GM at rest, after determination of muscle optimum length and at 2, 10 or 60 
minutes following a two-minute isometric contraction protocol. After the contractile 
activity required to determine the optimum length, the level of phospho
Thr287
-CaMKII 
for the δA isoform tended to be increased compared to rest in red GM. Levels of 
phospho
Thr287
-CaMKII were higher in GMW compared to GMR regardless of 
stimulation (βM: p<0.01, δA: p<0.01, δD/γB: p=0.01). In white GM, the level of total 
CaMKII decreased over time after stimulation (βM: p<0.01, δA: p=0.04, δD/γB: p=0.04). 
Our results suggest that phospho
Thr287
-CaMKII is increased after stimulation with 100 
twitches, but that this phosphorylation is only detectable within 15 minutes after 
contraction. 
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Introduction  
Calcium/calmodulin-dependent protein kinase II (CaMKII) has been suggested to 
regulate gene expression, calcium channels and glucose transport in skeletal muscle 
(Tavi et al., 2003, Wright et al., 2007, Witczak et al., 2010). The regulation of its 
activation likely determines in which context these functions are relevant. For example, 
if CaMKII is more strongly activated at high, compared to low, recruitment frequencies, 
it is likely to be more important for muscle function during high frequency muscle 
recruitment and muscle adaptation to such recruitment. CaMKII is activated by binding 
of calcium/calmodulin (Ca
2+
/CaM) (Hudmon and Schulman, 2002), and therefore, 
availability of Ca
2+
/CaM determines whether CaMKII is activated. It has been shown 
that CaMKII can be activated/phosphorylated in human skeletal muscle by exercise 
(Rose et al., 2006) and in rat fast-twitch muscle by in situ  electrical stimulation (Rose et 
al., 2007a). However, if and how this activation of CaMKII is regulated by the specific 
recruitment pattern is unknown.  
Following binding of Ca
2+
/CaM, CaMKII can undergo autophosphorylation at 
Thr287 and gain Ca
2+
/CaM-independent activity. In vitro, it has been shown that the 
generation of Ca
2+
/CaM-independent, or autonomous, CaMKII activity depends on the 
frequency, amplitude and duration of Ca
2+
/CaM pulses (De Koninck and Schulman, 
1998). Motor neuron firing rate is modulated during locomotor tasks in vivo, with slow-
twitch motor neurons firing between 5-40 Hz and fast-twitch motor neurons firing at 60-
300 Hz, depending on the specific locomotor task  (Hennig and Lomo, 1985, Gorassini 
et al., 2000). These motor unit recruitment frequencies are coupled to different 
frequencies of calcium release from the sarcoplasmic reticulum and/or differences in 
cytoplasmic calcium concentration changes (Westerblad and Allen, 1993), and it has 
been suggested that there is a positive relation between the recruitment frequency of 
muscle fibres and the amount of CaMKII activity developed during the period of muscle 
recruitement (Chin, 2005).  
This idea is supported by the finding that high (80% VO2max), but not low 
(40% VO2max) intensity cycling exercise increased phosphorylation of CaMKII at 
Thr287 immediately after exercise (Egan et al., 2010). Presumably, the higher muscle 
power output required for cycling at 80% VO2max was at least in part due to increased 
motor unit firing frequencies. However, when higher power outputs are required, it is 
24 
 
likely that a larger number of motor units is recruited (MacIntosh et al., 2000, Beltman 
et al., 2004) and therefore a different percentage of muscle fibres may be active at the 
site of the biopsy compared to the low intensity condition, which could affect the 
outcome of such studies.  
Of further importance is whether CaMKII activity remains elevated after 
exercise or is turned off. Autonomous CaMKII activity could theoretically outlast the 
calcium signal, but even during continued electrical stimulation this activity can be 
reduced within seven minutes in skeletal muscle (Rose et al., 2007a). A high-intensity 
cycling protocol resulted in increased levels of phospho
Thr287
-CaMKII in m. vastus 
lateralis “immediately” after exercise, but these levels had returned to the pre-exercise 
values at three hours post-exercise (Egan et al., 2010, Benziane et al., 2008). It is 
unknown how long CaMKII phosphorylation remained elevated after exercise in these 
studies.  
Finally, the consequences of the differences in calcium kinetics and 
concentration changes between slow- and fast-twitch muscles are unknown. Calcium 
transients in fast-twitch muscle rise faster, have a higher amplitude (20 µM vs. 10 µM) 
and decay faster (Baylor and Hollingworth, 2003). It has been hypothesised that, due to 
the slow kinetics of CaMKII activation relative to those of calcium concentration 
changes, the difference between slow- and fast-twitch fibres would not have significant 
effects on CaMKII signalling (Tavi and Westerblad, 2011). However, this has not been 
tested experimentally.   
To investigate whether CaMKII acts as a ‘decoder’ of calcium signals in 
skeletal muscle, we kept in situ stimulated muscles below slack length (i.e. left of the 
ascending limb of the force-length relationship) to uncouple the calcium influx from 
force production. We investigated whether CaMKII was differentially phosphorylated at 
Thr287 after high and low frequency stimulation. Because it is not known if the 
different CaMKII isoforms are differently activated by muscle stimulation, we analysed 
their phosphorylation separately. We stimulated three separate muscle compartments, 
slow-twitch m. soleus (SOL) and fast-twitch oxidative (GMR) and glycolytic (GMW) 
m.gastrocnemius in our experiments to assess whether effects of stimulation differ 
between different fibre types. To investigate whether phosphorylation of the CaMKII 
isoforms remains elevated after muscle stimulation, we measured its time course after 
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repeated tetanic contractions, which is thought to further activate CaMKII in rat GM 
(Rose et al., 2007a) 
 
We hypothesized that  
1) Phospho
Thr287
-CaMKII levels are higher after stimulation with pulses at 150 Hz 
compared to stimulation with the same number of pulses at 10 Hz.  
2) Phospho
Thr287
-CaMKII levels would increase more in the low oxidative GMW 
compared to high-oxidative GMR and SOL. 
3) Phospho
Thr287
-CaMKII levels are increased in stimulated muscle compared to non-
stimulated muscle at 10 minutes, but not at 60 minutes after the end of stimulation.  
 
Methods 
Animals 
Three month-old female Wistar rats (Harlan Laboratories; two-minute isometric 
contraction experiment: 191-230 grams, n=20; slack contraction experiment: 205-220 
grams, n=12) were anaesthetised initially by intraperitoneal injections of 1.2 ml/100 
gram body weight of 12.5% urethane. Ear and foot reflexes were tested to check 
whether the animal was sufficiently anaesthetised. Subsequent injections of 0.3-0.5 ml, 
up to a maximum of 1.5 ml, were given every 10 minutes afterwards until reflexes had 
disappeared. Rats were kept on a heated pad (±37 ºC) to prevent hypothermia. 
 
Muscle-tendon preparation   
Hind limbs were shaved and skin was removed, after which m. gastrocnemius medialis 
(GM) and m. soleus  (SOL) were exposed and mechanically isolated by removing as 
much as possible the myofascial connections to surrounding muscles. Blood supply to 
and nerve innervations of SOL and GM were kept intact. The calcaneus was cut from 
the talus, while still attached to the Achilles tendon. The sciatic nerve was dissected 
free, proximally severed and electrically stimulated through an external electrode 
controlled by a computer (50µs rectangular pulses).  
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Contraction protocols 
Effect of low and high frequency stimulation at short muscle length on phospho
Thr287
-
CaMKII levels 
 Experiments were performed at room temperature (23ºC). Muscles were kept below 
slack length because the used different stimulation frequencies would result in different 
muscle forces and energy consumption patterns if the muscles were kept at optimum 
length. Rats were divided into two groups: 1) GM and SOL stimulated at 10 Hz.  2) GM 
and SOL stimulated at 150 Hz stimulation. Muscles of the right leg were stimulated. As 
CaMKII is phosphorylated within seconds after the start of contraction (Rose et al., 
2007a) both groups received a total of 100 pulses (stimulation current: 3mA; pulse 
duration: 50 µs). The total duration of stimulation was 10 seconds for the 10 Hz group 
and 0.67 seconds for the 150 Hz group). After stimulation, GM and SOL were dissected 
as rapidly as possible and snap-frozen in liquid nitrogen. The first muscle was typically 
sampled after 1 minute, the second after 2 minutes. In half of the experiments, SOL was 
sampled first, and in the other half GM was sampled first. Subsequently, the non-
stimulated left muscles were dissected and snap-frozen. Rats were killed by intracardial 
injection of Euthasol® while fully anaesthetised. Muscles were stored at -80°C until 
used for western blot analysis. 
 
Time course of CaMKII phosphorylation after muscle contractions 
The temperature of GM was kept at approximately 35°C using an envelope into which 
warm water vapour was sprayed. The Achilles tendon was tied to a Kevlar thread, 
which was subsequently attached to a force transducer. Force data were sampled at a 
frequency of 1000 Hz. Optimum muscle length (the length of the muscle-tendon 
complex at which maximum tetanic force was produced) was estimated using twitches, 
and subsequently determined using 3-4 tetanic contractions. GM rested for two minutes 
between each tetanic contraction and for 15 minutes after determination of optimum 
length. A stimulation protocol consisting of a series of 24 pulse trains was then applied 
(stimulation current: 3mA; pulse duration: 50 µs), resulting in tetanic maximal isometric 
contractions (stimulation frequency: 150Hz; 1 train every 5 s; train duration: 200 ms). 
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This protocol resulted in a decrease in maximal tetanic force of approximately 30% 
(Fig. 1)   
 
 
Figure 1: Decrease in 
tetanic force during the 
‘two-minute isometric’ 
contraction protocol 
Data are displayed as 
means ±SEM. Note that 
the error bars are barely 
visible because they are 
often smaller than the 
symbols indicating the 
mean relative titanic force.    
 
 
 
 
Five groups of muscles were defined by the time point of sampling: 1) resting; 2) 
optimum length determination (LOPT; 3) two minutes after the contraction protocol; 4) 
10 minutes after the contraction protocol; 5) 60 minutes after the contraction protocol 
(Fig. 2). At the defined time points, GM was dissected and snap-frozen in liquid 
nitrogen. Animals were killed by intra-cardiac injection of Euthasol®, while still fully 
anaesthetised. Frozen muscles were stored at -80ºC until used for western blotting. 
 
 
 
  
Figure 2: Experimental design of the ‘two-minute isometric’ contraction protocol. 
Left and right m. gastrocnemius medialis of the animals were randomly assigned to one of five 
groups: rest, LOPT, 2 min post, 10 min post or 60 min post. The imposed stimulation and periods 
of rest following stimulation are described in this figure. Details of the ‘2 min isometric 
contractions’ protocol can be found in the methods section. At the end of the prescribed 
stimulation protocol/resting period, the muscles were dissected and frozen in liquid nitrogen.   
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Protein analysis 
Frozen muscle was cut into 25 µm thick cross-sections in a cryostat, which were 
collected in a 2 ml tube and kept at -20ºC. Chemicals were obtained from Sigma-
Aldrich (Poole, United Kingdom) unless stated otherwise.  Ice-cold RIPA buffer (50mM 
TRIS-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% v/v Non-Idet P40 substitute, 
0.25% w/v sodium deoxycholate plus freshly added protease/phosphatase inhibitors: 1 
mM NaF, 1 mM Na3VO4, 0.1 mM PMSF, 1µg/ml leupeptin, 0.2 µg /ml pepstatin, 0.1 
µg/ml aprotinin) was then added and sections were homogenised on ice using a Polytron 
homogeniser (Kinematica AG, Luzern, Switzerland). Crude homogenates were 
aspirated 5-10 times through a 0.8 mm syringe needle, and stored at -80ºC until use for 
analysis. An aliquot of the aspirated homogenate was taken for determination of protein 
concentration with the bicinchoninic acid protein assay (Pierce, Rockford IL, USA). 
Protein levels of total CaMKII, phospho
Thr287
-CaMKII and cytochrome-c 
oxidase subunit IV (COXIV) were analysed by western blotting followed by 
immunodetection. Homogenates were denatured by addition of sample buffer (final 
concentration: 50mM TRIS-HCl (pH 6.8), 2% w/v SDS, 10% v/v glycerol, 2% β-
mercaptoethanol) and 5 minutes heating at 95ºC. 20 µg of protein was separated by 
SDS-PAGE and transferred overnight onto a nitrocellulose membrane (GE Healthcare 
Life Sciences, Little Chalfont, United Kingdom), while transfer buffer was cooled in 
ice. Membranes were stained with Ponceau S solution to confirm equal protein loading 
and transfer. The stain was washed off with TRIS-buffered saline with tween-20 (TBS-
T; 20mM TRIS-HCl (pH 7.5), 0.9% w/v NaCl, 0.05% Tween-20) and the membrane 
was blocked in antibody incubation solution, followed by incubation with a primary 
antibody for either pan-CaMKII (BD Bioscience, #611292, dilution: 1/2500), 
phospho
Thr287
-CaMKII (Cell Signalling Technology #3361, dilution: 1/1000) or COXIV 
(Cell Signalling Technology, #4850, dilution 1/2000) for two hours. Antibody 
incubation solutions were 5% milk in TBS-T (for pan-CaMKII) or 5% bovine serum 
albumin (BSA) in TBS-T (for phospho
Thr287
-CaMKII). Residual antibody was washed 
away with 4 washes of 5 minutes in TBS-T, followed by incubation with species-
specific horseradish peroxidase-conjugated secondary antibodies. Antibodies were 
detected with an enhanced chemiluminescence kit (Pierce, Rockford IL, USA). Light 
signals were captured with a ChemiDoc XRS system (Biorad, Hemel Hempstead, 
United Kingdom).  
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Samples from all experimental groups from the in situ contraction experiments 
were analysed on the same blot, so direct comparisons of protein expression could be 
made. Protein bands were quantified with Quantity One version 4.6.8 (Biorad). 
Background-corrected band intensities on each blot were normalized to the sum of the 
intensities of the same band in all lanes to correct for differences in overall staining 
intensity of the blots. The obtained values were related to the mean of the ‘rest’ group.  
 
In vitro CaMKII phosphorylation 
To ensure specificity of the phospho
Thr287
-CaMKII antibody in our setup and to detect 
calcium/calmodulin-sensitive protein bands, CaMKII was phosphorylated in vitro by 
incubating 5 µl of crude muscle homogenate with a reaction mix containing 
calcium/calmodulin (Enzo Life Sciences, Exeter, United Kingdom) (total volume: 50 µl; 
0.1 mM ATP, 10 mM HEPES (pH 7.4), 5 mM MgCl2, 0.1% Tween-20 and 0.5 mM 
CaCl2 + 1 µM calmodulin or 5 mM EGTA) for 30 minutes at 30ºC. The reaction was 
stopped by the addition of 16.7 µl 4x sample buffer. Samples were heated to 95 ºC and 
proteins were separated with SDS-PAGE on a 15% acrylamide (Biorad) gel and 
subjected to western blotting as described. Based on data from (Bayer et al., 1998), we  
identified the detected CaMKII bands as βM (72 kDa), δA (60 kDa) and a combination of 
δD and γB (58 kDa).        
 
Muscle compartments  
Red and white portions of GM (GMR and GMW, respectively), which contains 
compartmentalised fibres with high or low oxidative capacity (De Ruiter et al., 1995), 
were analysed separately. Tissue from GMR or GMW was obtained by cutting 
cryosections from the proximal or distal end of the frozen muscle, respectively.     
 
Statistics 
Slack contraction protocol 
The effect of stimulation on total and phospho
Thr287
-CaMKII levels was tested with 
factorial ANOVAs (stimulation x frequency), with repeated measures on the factor 
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stimulation. The effect of stimulation frequency was tested by assessing the interaction 
between stimulation and frequency.  These tests were performed separately for GMR, 
GMW and SOL. We expected phospho
Thr287
-CaMKII to increase in stimulated muscles 
(Rose et al., 2007a). Therefore, one-sided post-hoc tests were carried out to analyse the 
effect of stimulation on phospho
Thr287
-CaMKII. Comparisons between muscles 
stimulated at a specific frequency and their intra-animal resting controls were made with 
Wilcoxon signed ranks tests 
 
Two-minute isometric contraction protocol.    
The effect of stimulation on total and phospho
Thr287
-CaMKII levels was tested with 
Kruskal-Wallis ANOVAs for GMR and GMW. Mann-Whitney U-tests were used to test 
differences between individual time points within one compartment and Wilcoxon 
signed ranks tests were used to test differences between compartments at one specific 
time point. Correlations between COXIV and phospho
Thr287
-CaMKII were tested with 
Spearmon’s Rho. Significance level was set at p≤ 0.05.  
 
Results 
The acute effects of stimulation frequency on total and phospho
Thr287
-CaMKII in 
GM and SOL 
We investigated CaMKII phosphorylation in GMR, GMW and SOL after stimulation 
with 100 pulses at 10 or 150 Hz. In GMR, we observed a significant increase in 
phospho
Thr287
-CaMKII for the δA and δD/γB, but not for the βM isoform (βM: p=0.066; δA: 
p=0.048; δD/γB: p= 0.050). In GMW, we observed a significant increase in δA only (βM: 
p=0.114; δA: p=0.043; δD/γB: p= 0.447), whereas in SOL none of the phospho
Thr287
-
CaMKII isoforms was significantly increased (Fig. 3). We did not observe an 
interaction effect between stimulation and frequency on phospho
Thr287
-CaMKII in GMR, 
GMW or SOL.  
 
Surprisingly, we observed a decrease in total CaMKII in GMW after 150 Hz stimulation 
(Wilcoxon signed ranks test; βM: p=0.03, δA: p=0.44, δD/γB: p=0.03), but not after 10 Hz 
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stimulation (stimulation x frequency interaction: βM: p=0.03, δA: p=0.22, δD/γB: p=0.03) 
(Fig. 4). Such a decrease was not observed in GMR or SOL (Fig. 4). 
For all muscles, there was no difference in actin levels on the blots between 
resting and stimulated samples (GMR: p=0.21; GMW: p=0.22; SOL: p=0.40) and no 
statistical interaction effect between stimulation and frequency on actin levels (GMR: 
p=0.47; GMW: p=0.72; SOL: p=0.52) (Appendix, Fig. A1).  
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Figure 3: PhosphoThr287-CaMKII levels in rat m. gastrocnemius medialis and m. soleus 
samples after slack contractions.  
Graphs display phosphoThr287-CaMKII levels for βM, δA and δD/γB as determined by western 
blotting followed by immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: SOL, 
βM-CaMKII; D: GMR, δA-CaMKII; E: GMW, δA-CaMKII; F: SOL, δA-CaMKII; G: GMR, δD/γB-
CaMKII; H: GMW, δD/γB-CaMKII; I: SOL, δD/γB-CaMKII. Bars represent mean phospho
Thr287-
CaMKII levels and symbols represent the amount of phosphoThr287-CaMKII in individual muscles. 
Same symbols represent muscles from the same animal within one frequency group. Muscles 
connected by a dashed line are intra-animal pairs. Note the different scales of different graphs. 
GMR = High oxidative, (red) m. gastrocnemius medialis. GMW = low oxidative (white) m. 
gastrocnemius medialis. SOL = m. soleus.  Rest- xxHz denotes non-stimulated muscle, contra-
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lateral to the muscle stimulated at xx Hz which is denoted by Stim – xxHz. Significance of 
stimulation effect is indicated in each graph. A.U. = arbitrary units. Examples of phosphoThr287-
CaMKII immunoblots and poncesu s-stained actin bands are shown below the graphs. J: GMR; K: 
GMW; L: SOL.      
 
 
 
 
Figure 4: Decrease in total CaMKI in rat white m. gastrocnemius medialis after slack 
contractions. 
Graphs display total CaMKII levels for βM, δA and δD/γB as determined by western blotting 
followed by immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: SOL, βM-
CaMKII; D: GMR, δA-CaMKII; E: GMW, δA-CaMKII; F: SOL, δA-CaMKII; G: GMR, δD/γB-
CaMKII; H: GMW, δD/γB-CaMKII; I: SOL, δD/γB-CaMKII. Bars represent mean total CaMKII 
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levels and symbols represent the amount of total CaMKII in individual muscles. Same symbols 
represent muscles from the same animal within one frequency group. Muscles connected by a 
dashed line are intra-animal pairs. Note the different scales of different graphs. GMR = High 
oxidative, (red) m. gastrocnemius medialis. GMW = low oxidative (white) m. gastrocnemius 
medialis. SOL = m. soleus.  Rest- xxHz denotes non-stimulated muscle, contra-lateral to the 
muscle stimulated at xx Hz which is denoted by Stim – xxHz. Significance of stimulation effect is 
indicated in each graph. A.U. = arbitrary units. Examples of total CaMKII immunoblots and 
ponceau s-stained actin bands are shown below the graphs. J: GMR; K: GMW; L: SOL.      
 
The effect of two-minute isometric contractions on total and phospho
Thr287
-
CaMKII in red and white GM compartments 
We investigated CaMKII phosphorylation in the two compartments of GM after a two-
minute isometric protocol. For both compartments, we did not observe a significant 
main effect of stimulation on phospho
Thr287
-CaMKII for any of the isoforms (GMR: βM: 
p=0.33, δA: p=0.09, δD/γB: p=0.157; GMW: βM: p=0.91, δA: p=0.75, δD/γB: p=0.27). 
When the mean phospho
Thr287
-CaMKII levels at the time points at which these were 
highest for each CaMKII isoform were compared to phospho
Thr287
-CaMKII levels in the 
resting muscles, we only observed a trend for an increase in the δA isoform in GMR 
after the contractile activity necessary to determine the optimum length (Fig. 5). 60 
Minutes after stimulation, phospho
Thr287
-CaMKII levels tended to be decreased for βM 
and δA isoforms compared to the time point at which mean phospho
Thr287
-CaMKII levels 
were highest (Fig. 5). No significant differences in phospho
Thr287
-CaMKII between 
individual time points were observed for any of the isoforms in GMW.  
 
All isoforms showed higher phospho
Thr287
-CaMKII levels in rested GMW compared to 
rested GMR (Main effect of compartment: βM: p<0.01, δA: p<0.01, δD/γB: p=0.01) (Fig. 
5). This difference was significant in the resting muscles for the βM (p=0.02) and δA 
(p=0.03) isoforms, and was associated with a higher aerobic capacity in GMR, as 
reflected by a higher COXIV protein expression in GMR (p=0.03; Fig. 6). There was no 
difference in total CaMKII in rested muscles (Fig. 7).  
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Figure 5: PhosphoThr287-CaMKII in rat m. gastrocnemius medialis samples before and after a 
two-minute isometric contraction protocol.  
Graphs display phosphoThr287-CaMKII levels as determined by western blotting followed by 
immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: GMR, δA-CaMKII; D: 
GMW, δA-CaMKII. E: GMR, δD/γB-CaMKII; F: GMW, δD/γB-CaMKII. Bars represent mean 
phosphoThr287-CaMKII levels and symbols represent the amount of phosphoThr287-CaMKII in 
individual samples. Amounts are relative to the mean of the resting GMR samples. The dashed 
line represents the mean level of phosphoThr287-CaMKII in the resting GMR samples.G: Examples 
of immunoblot for phosphoThr287-CaMKII in GMR and GMW, and ponceau s-stained actin bands. 
A.U. = arbitrary units. GMR = High oxidative (red) m. gastrocnemius medialis. GMW = low 
oxidative (white) m. gastrocnemius medialis. 
 
 
 
 
Figure 6: COXIV protein expression in oxidative and glycolytic m. gastrocnemius   
A: Graph displays COXIV levels as determined by western blotting followed by 
immunodetection. Bars represent mean COXIV levels and symbols represent the amount of 
COXIV in individual samples. Muscles connected by a dashed line are intra-animal pairs. 
Significance of the difference between red and white GM is indicated. B: Example COXIV 
immunoblot is shown below the graph. R = red GM; W = white GM. 
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Total CaMKII was significantly decreased after stimulation in GMW (Main effect of 
stimulation: βM: p<0.01, δA: p=0.04, δD/γB: p=0.04), but not in GMR (βM: p=0.13, δA: 
p=0.89, δD/γB: p=0.49) (Fig. 7).   
 
There were no differences in actin levels on the blots (GMR phospho
Thr287
-CaMKII 
blots: p=0.80; GMR, total CaMKII blots: p=0.96; GMW, phospho
Thr287
-CaMKII blots: 
p=0.99; GMW, total CaMKII blots: p=0.94; Appendix, Fig. A2) indicating equal protein 
loading in all conditions. 
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Figure 7: Total CaMKII in rat m. gastrocnemius medialis samples before and after a two-
minute isometric contraction protocol.   
Graphs display total CaMKII levels as determined by western blotting followed by 
immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: GMR, δA-CaMKII; D: 
GMW, δA-CaMKII. E: GMR, δD/γB-CaMKII; F: GMW, δD/γB-CaMKII. Bars represent mean total 
CaMKII levels and symbols represent the amount of total CaMKII in individual samples. 
Amounts are relative to the mean of the resting GMR samples. The dashed line represents the 
mean level of total CaMKII in the resting GMR samples. P-values in the figure indicate 
significance of the difference compared to the ‘rest’ group. G: Examples of immunoblot for total 
CaMKII in GMR and GMW and ponceau s-stained actin bands. A.U. = arbitrary units. GMR = 
High oxidative (red) m. gastrocnemius medialis. GMW = low oxidative (white) m. gastrocnemius 
medialis. 
 
 
Discussion  
 
Main results  
Our results suggest that stimulation of GM with 100 twitch pulses can increase 
autophosphorylation of CaMKII (Fig. 3). However, in contrast to our hypothesis, we did 
not observe significant differences in phospho
Thr287
-CaMKII after low and high 
frequency stimulation (Fig. 3). We observed higher basal phospho-CaMKII levels in 
GMW compared to GMR (Fig. 5). Finally, we observed an unexpected decrease in total 
CaMKII in GMW after high-frequency stimulation (Fig. 4 & Fig. 7).  
 
Technical considerations 
After both the ‘two minute isometric contraction’ protocol and ‘slack contraction’ 
protocol we observed a large variability in phospho
Thr287
-CaMKII levels in SOL and 
GM compartments (Fig. 3 & Fig. 5). Autophosphorylation of CaMKII at Thr287 occurs 
only when two Ca
2+
/CaM-bound subunits interact (Hanson et al., 1994, Rich and 
Schulman, 1998). Autophosphorylation increases Ca
2+
/CaM affinity many fold (Meyer 
et al., 1992) and therefore, small differences in the fraction of autophosphorylated 
CaMKII subunit could lead to large differences in the rate of autophosphorylation. In 
vitro, it has been demonstrated that the development of autonomous CaMKII activity 
displays very high sensitivity to changes in [Ca
2+
] when interacting with protein 
phosphatase 1 (PP1) (Bradshaw et al., 2003). It may be that variability in intracellular 
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[Ca
2+
] in our experiments contributed to the observed variation in phospho
Thr287
-
CaMKII.    
Some non-stimulated samples had higher phospho
Thr287
-CaMKII levels 
compared to the average level in stimulated samples (Fig. 3 & Fig. 5). This indicates 
that factors other than muscle stimulation affect phospho
Thr287
-CaMKII levels in skeletal 
muscle. Our observation that resting phospho
Thr287
-CaMKII was higher in GMW 
compared to that in GMW suggests that the level of phospho
Thr287
-CaMKII is related to 
the oxidative capacity of the muscle. However, we did not observe a significant 
correlation between phospho
Thr287
-CaMKII and COXIV protein levels within these 
compartments (GMR: Rho=0.27; GMW: Rho=0.33), suggesting that the variation in 
phospho
Thr287
-CaMKII levels cannot be explained by differences in oxidative capacity 
within the GM compartments. 
Auto-phosphorylation of CaMKII at Thr287 is not the only mechanism that 
regulates the activity of the kinase. Ca
2+
/CaM-dependent activity may play an important 
role in intracellular signalling. Furthermore, kinase activation is also regulated by 
autophosphorylation of Thr306/307. These residues are in the CaM-binding domain and 
their phosphorylation inhibits CaM binding to this domain (Hanson and Schulman, 
1992, Colbran, 1993). Finally, Met281/282 of CaMKII can be oxidized, which is a 
parallel mechanism of activation to autophoshorylation at Thr287 (Erickson et al., 
2008). Although a previous study has found that levels of phospho
Thr287
-CaMKII and 
autonomous CaMKII activity correlated quite well in rat skeletal muscle (Rose et al., 
2007a), it is possible that the levels of phospho
Thr287
-CaMKII in our study do not 
perfectly reflect CaMKII activity.    
 
Implications for CaMKII-signalling in skeletal muscle  
We observed lower phospho
Thr287
-CaMKII levels in the red compared to the white 
compartment of GM (Fig. 5). Basal phosphorylation levels of mitogen-activated protein 
kinases p38, p42 and p44, and AMP-activated protein kinase (AMPK) have also been 
shown to be lower in the ‘red‘, compared to the ‘white’ rat m. tibialis anterior 
compartment (Ljubicic and Hood, 2008). Autophosphorylation at Thr287 increases the 
affinity of CaMKII for Ca
2+
/CaM manyfold (Meyer et al., 1992). Therefore, Ca
2+
-CaM-
dependent CaMKII activity in GMW may be sensitised to changes in [Ca
2+
]i.  
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CaMKII has been implicated as a regulator of the ‘slow oxidative’ muscle 
phenotype (Mu et al., 2007) and mitochondrial biogenesis (Wright et al., 2007). 
However, slow-twitch m. soleus was the only muscle compartment in which none of the 
CaMKII isoforms displayed increased autophosphorylation in response to the slack 
contraction protocol. Furthermore, GMW has a higher level of phospho
Thr287
-CaMKII 
than GMR (Fig. 5). These results suggest a negative association of CaMKII-signalling 
with features of the slow-oxidative phenotype. Possibly, the lower amplitude of calcium 
concentration changes in m. soleus compared to m. gastrocnemius medialis (Baylor and 
Hollingworth, 2003) can explain the absence of an increase in CaMKII 
autophosphorylation in SOL, which could be reflective of the effect of training on acute 
CaMKII signalling. Similarly, it has been shown that AMPK activation is attenuated in 
trained skeletal muscle, and that this is associated with a reduction in the activating 
signal (i.e. the AMP: ATP ratio) after training (McConell et al., 2005). Training-induced 
changes in muscle phenotype may have a similar effect on CaMKII signalling by 
altering calcium cycling in skeletal muscle (Green et al., 2003). In contrast to this 
hypothesis, CaMKII autophosphorylation in human skeletal muscle was not attenuated 
after a 10 day exercise training program (Benziane et al., 2008). However, this training 
protocol was possibly not sufficient to induce changes in the expression of calcium-
regulatory proteins.   
We found no evidence for an effect of motor unit recruitment frequency on 
phospho
Thr287
-CaMKII levels (Fig. 3). It is possible that the recruitment frequencies used 
in this study and those occurring in skeletal muscle in vivo are too high to be converted 
into differing amounts of autonomous kinase activity. In vitro, frequency-dependence of 
CaMKII autophosphorylation was shown for frequencies between 1 and 4 Hz (De 
Koninck and Schulman, 1998). However, the duration of these pulses was much longer 
than the duration of a Ca
2+
 pulse in fast- and slow-twitch skeletal muscle fibres (200 ms 
vs. 50-100 ms (Baylor and Hollingworth, 2003)), and decreasing the duration of the 
Ca2+-pulse shifted the frequency-autonomous activity relation towards higher 
frequencies (De Koninck and Schulman, 1998). Thus, although CaMKII might be 
differentially activated by in vivo-relevant muscle recruitment frequencies, this is not 
exhibited in skeletal muscle after electrical stimulation.   
Our data indicate that phospho
Thr287
-CaMKII decreases during a one-hour time 
course after cessation of stimulation (Fig. 5). Combining results from the slack 
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experiments (Fig. 3) and the two-minute isometric contraction protocol (Fig. 5) suggests 
that increases in phospho
Thr287
-CaMKII are detectable within the first two minutes after 
contraction but not after 15 minutes. Different protein phosphatases (PP1, PP2A, PP2C) 
can de-phosphorylate Thr286 (the alpha-CaMKII homologue of Thr287) in rat forebrain 
neurons (Strack et al., 1997), and as these are also expressed in skeletal muscle (Cohen, 
1989), they may play a role in regulating CaMKII phosphorylation in skeletal muscle.  
 
Muscle phenotype-specific decrease in total CaMKII  
In both the slack contraction experiment and the two-minute isometric contractions 
protocol, total CaMKII was decreased in GMW after stimulation with pulses at 150 Hz, 
but not with 10 Hz stimulation (Fig. 4 & Fig. 7). The stimulated samples in the slack 
experiment were always sampled before the resting controls. This suggests the decrease 
in total CaMKII was due to factors related to stimulation, and were not an artifact of the 
experimental setup.   
This raises the question as to what caused the decrease in total CaMKII in 
white GM. Given the time frame in which this effect occurred, there are three potential 
explanations: 1) A post-translational modification of the protein reduced the antigenicity 
of the CaMKII antibody for its epitope, or binding to the membrane during blotting. 2) 
Translocation of CaMKII to a non-soluble subcellular fraction, which prevented it from 
entering the gel during SDS-PAGE. 3) Degradation of CaMKII. The last option cannot 
explain the acute decrease in total CaMKII observed in GMW during the slack 
experiment, but degradation of CaMKII could be partially involved in explaining the 
difference between total CaMKII levels 60 minutes post-stimulation compared to that of 
resting muscle (Fig. 7).  
Currently, no posttranslational modifications of CaMKII are known in the 
association domain of the protein, which is where our CaMKII antibody binds according 
the specifications given by the manufacturer (immunogen: rat alpha CaMKII 
aminoacids 448-460). In neurons, CaMKII has been shown to be able to translocate to 
different compartments of the cell upon stimulation by Ca
2+
/CaM (Bayer and Schulman, 
2001). However, whether this occurs in muscle, what the target binding sites are, and 
whether these fractions would not be solubilised in our protein extraction procedure, is 
unknown. It should be noted that our protocol did solubilise and separate the βM 
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isoform, which is targeted to the SR membrane via anchoring protein αKAP (Bayer et 
al., 1998). 
Finally, degradation of CaMKII protein might have occurred. The Ca
2+
-
dependent protease µ-calpain can degrade CaMKII into 30-35 kDa fragments 
(Hajimohammadreza et al., 1997, Yoshimura et al., 1996), and mice overexpressing the 
calpain-inhibitor calpastatin have increased CaMKII protein levels (Otani et al., 2006). 
These studies indicate that CaMKII is subject to degradation by calpains in skeletal 
muscle. We have found no evidence of immunoreactive bands on our western blots with 
an approximate molecular weight of 30-35 kDa. It is therefore unclear what caused the 
observed decrease in total CaMKII in GMW.  
Note that in previous experiments in which rat GM was stimulated in situ a 
decrease in total CaMKII was not detected (Rose et al., 2007a). However, in this study 
red and white GM were not separately analysed, whereas our data suggest that muscle 
phenotype has a significant effect on the decrease in detected total CaMKII.   
 
Conclusion 
Our results suggest that CaMKII can be autophosphorylated by a short contraction 
protocol, but that this phosphorylation is only detectable within 15 minutes after 
contraction. Furthermore, other factors than stimulation appear to strongly affect 
CaMKII phosphorylation. We detected a decrease in total CaMKII after high-frequency 
stimulation in fast glycolytic muscle. Therefore, investigations into interactions of other 
factors than Ca
2+
/CaM with CaMKII signalling in skeletal muscle are warranted.  
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Appendix: Western blot loading controls 
 
 
 
 
 
 
 
Figure A1: Western blot loading controls for ‘slack contraction’ experiments 
Graphs displaying quantifications of ponceau s-stained actin on blots of muscle samples from the 
‘slack contraction’ experiment. Data are displayed as means ± S.E.M. Note that the graphs have 
different scales. GMR = High oxidative (red) m. gastrocnemius medialis. GMW = Low oxidative 
(white) m. gastrocnemius medialis. SOL = m.soleus. 
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Figure A2: Western blot loading controls for ‘2 minutes isometric contraction’ experiments 
Graphs displaying quantifications of ponceau s-stained actin on blots of muscle samples from the 
‘2 minutes isometric contraction’ experiment. Data are displayed as means ± S.E.M. GMR = High 
oxidative (red) m. gastrocnemius medialis. GMW = Low oxidative (white) m. gastrocnemius 
medialis.  
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Abstract 
 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is the main CaMK in 
skeletal muscle and its expression increases with endurance training. Because CaMKII 
has been implicated as a regulator of mitochondrial biogenesis and calcium handling, 
we investigated the effects of acute CaMKII overexpression in skeletal muscle in vivo. 
We overexpressed α/β-CaMKII in adult rat m. gastrocnemius (GM) and m. soleus 
(SOL) via gene electro-transfer. CaMKII overexpression did not alter cytochrome c 
oxidase IV (COXIV) protein levels in either GM or SOL. Likewise, mRNA levels of 
oxidative phosphorylation components COXIV, COXI and the transcriptional 
coactivator PGC-1α were not different between empty- and CaMKII-transfected m. 
soleus, whereas succinate dehydrogenase subunit b mRNA was decreased in CaMKII-
transfected m. soleus (-26%, p<0.05). Force parameters of transfected muscles were 
measured in situ with intact innervations and perfusion. Strength and fatigue resistance 
of control- and CaMKII-transfected soleus and gastrocnemius did not differ. However, 
CaMKII overexpression decreased twitch time-to-peak force (p<0.05) and half-
relaxation time (p<0.05). In addition, CaMKII-overexpressing m. soleus fibres 
displayed increased sarco/endoplasmic reticulum Ca
2+
-ATPase 2 expression compared 
to non-transfected fibres (p<0.001). Our results suggest that CaMKII is not sufficient for 
mitochondrial biogenesis, but regulates the contractile muscle phenotype.   
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Introduction  
 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a multimeric 
phosphotransferase which can decode calcium transients through autophosphorylation at 
threonine287 (De Koninck and Schulman, 1998). In heart muscle cells, CaMKII is 
known to control ion channels and gene expression (Anderson et al., 2011). In skeletal 
muscle, CaMKII has been shown to be the main multifunctional CaMK and its 
phosphorylation at threonine287 and activity are increased during acute exercise bouts 
in rats and humans (Rose et al., 2007a, Rose et al., 2006). CaMK activation has been 
implied to regulate mitochondrial biogenesis (Wu et al., 2002, Ojuka et al., 2003, 
Wright et al., 2007) and calcium re-uptake into the sarcoplasmic reticulum (SR) via a 
possible effect on SERCA2 (Hawkins et al., 1994). This, and the observation that 
endurance exercise training increases total CaMKII protein expression (Benziane et al., 
2008, Rose et al., 2007b) suggest a role for CaMKII in the control of muscle plasticity.  
 Our current understanding of the physiological role of native CaMKII 
holoenzymes in whole muscle is limited, as it has been mainly derived from the 
characterisation of the effects of germline overexpression of a constitutively active 
CaMKIV mutant (Wu et al., 2002), which has lost its calcium-dependent regulation, and 
is not expressed in skeletal muscle (Akimoto et al., 2004). Furthermore, our current 
understanding of the role of CaMKII in calcium handling and fatigue in skeletal muscle 
is derived from in vitro studies (Hawkins et al., 1994) and short-term inhibition studies 
with pharmacological agents in single muscle fibres (Tavi et al., 2003). However, 
skeletal muscle fibres exist as a continuum of contractile phenotypes with distinct 
differences in calcium handling (Baylor and Hollingworth, 2003) and recruitment 
patterns (Hennig and Lomo, 1985). This indicates that pronounced differences in 
CaMKII-mediated calcium sensing and downstream effects may exist between 
functionally distinct muscle types.  
We hypothesised that hetero-multimeric CaMKII controls the mitochondrial 
and contractile phenotype of skeletal muscle via regulation of gene expression, and that 
this would differ between a slow-twitch and fast-twitch muscle of the lower leg (i.e. m. 
soleus (SOL) and m. gastrocnemius (GM)), due to differences in fibre recruitment in 
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these muscles during self-initiated locomotion (Gorassini et al., 2000). We tested this by 
assessing the effects of somatic co-overexpression of native alpha- and beta-CaMKII 
isoforms, with similar substrate specificity and structure as the muscle isoforms  
(Woodgett et al., 1984, Gaertner et al., 2004), on selected molecular markers of the 
contractile and mitochondrial phenotype, and functional characteristics of the targeted 
soleus and gastrocnemius medialis muscles. 
 
Methods  
 
Ethical approval 
A total of 23 female Wistar rats were used for the experiments described here. In situ 
contraction protocols and the majority of the transfection experiments were carried out 
at the MOVE Research Institute Amsterdam, VU University Amsterdam, The 
Netherlands and approved by the local Animal Experiments Committee. Two 
transfection experiments were carried out at the Department of Cardiovascular Surgery, 
University Hospital Bern, Switzerland and approved by the animal protection 
commission of the Canton of Berne, Switzerland. 
 
Somatic overexpression of CaMKII 
Plasmids 
PCDNA3 vectors encoding full-length cDNA for CaMKIIα and CaMKIIβ were a gift 
from Dr. M Neal Waxham (University of Texas, Houston, USA). PGL2 plasmid 
encoding full-length luciferase under control of 424 basepairs upstream of the 
transcription start site of the chicken skeletal alpha-actin gene (Marsh et al., 1998) was a 
gift from Dr. Frank W. Booth (University of Missouri, Columbia, USA).   
 
Transfection 
Three month-old female Wistar rats (Harlan Laboratories/Charles River; 191-230 
grams, n=13) were used to overexpress CaMKII in GM and SOL. The animals were 
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anaesthetised with 2-4% isoflurane through inhalation. Hind limbs were shaved, and 
skin was disinfected with 70% ethanol. An incision was made into the skin and fascia 
between GM and m. tibialis anterior. SOL was subsequently exposed and liberated, 
after which four injections of a plasmid mixture with a total volume of 90 µl were 
administered intramuscularly with a 29-gauge insulin syringe. GM was administered 
four injections over the length of the muscle with a total volume of 180 µl. A mix of 
expression plasmid for full-length CaMKIIα (pCDNA3-CaMKIIα; 0.22 µg/µl) and full-
length CaMKIIβ (pCDNA3-CaMKIIβ; 0.22 µg/µl) in TBE buffer was injected into 
muscles of the right leg together with the -424 skeletal alpha-actin reporter plasmid 
(0.55 µg/µl). Data obtained from this reporter construct are beyond the scope of this 
chapter, and are therefore reported in a separate chapter. Muscles of the left leg were 
injected with the reporter plasmid only (1 µg/µl). Right and left transfected muscles will 
henceforth be referred to as ‘CaMKII-transfected’ and ‘control-transfected’, 
respectively. DNA injection was followed by electroporation with a GET42 
electropulser (E.I.P. Electronique et Informatique du Pilat, Jonzieux, France). Needle 
electrodes were placed along SOL or into GM and pulse protocols were applied as 
described previously (Durieux et al., 2009). 
After electroporation, the skin wound was closed with sutures, and the animal 
was allowed to recover from anaesthesia. Animals were kept in cages afterwards, where 
they resumed normal activity within hours after surgery. After seven days, animals were 
anaesthetised for measurement of muscle contraction parameters (see below), sacrificed 
by intra-cardiac injection of Euthasol® (VU University Amsterdam) or anaesthetised 
with 3% isoflurane and euthanised by dislocation of the cervical vertebrae and rapid 
exsanguination (University Hospital Bern). Transfected muscles were harvested from 
both legs and snap-frozen in liquid nitrogen. 
 
Muscle-tendon complex preparation  
For measurement of  isometric muscle contraction parameters, rats were anaesthetised 
by intra-peritoneal injections of 1.2 ml/100 gram body weight of 12.5% urethane (De 
Haan et al., 2003). Ear and foot reflexes were tested to check whether the animal was 
sufficiently anaesthetised. Subsequent injections of 0.3-0.5 ml, up to a maximum of 1.5 
ml, were given every 10 minutes afterwards until reflexes had disappeared. Experiments 
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were carried out at room temperature (24ºC). Rats were kept on a heated pad to prevent 
hypothermia. Hind limbs were shaved and skin was removed, after which GM and SOL 
were exposed and mechanically isolated by removing as much as possible the 
myofascial connections to surrounding muscles. Blood supply to, and nerve 
innervations of, both muscles were kept intact and tendons of GM and SOL were 
attached to a force transducer via Kevlar wires. The sciatic nerve was severed 
proximally and received stimulation with rectangular pulses through an external 
electrode controlled by a computer. Force data were sampled at a frequency of 1000 Hz.  
 
Activation of exogenous CaMKII in transfected skeletal muscle 
A two-minute stimulation protocol consisting of either intermittent isometric tetanic 
contractions at 100Hz stimulation frequency (Rose et al., 2007a), or continuous 
stimulation at 10Hz was applied to α/β-CaMKII overexpressing GM and SOL in situ. 
The muscles (n=6) were freeze-clamped between liquid nitrogen-cooled aluminium 
grips during stimulation after two minutes. Non-stimulated, α/β-CaMKII overexpressing 
contra-lateral muscles were subsequently dissected and frozen in liquid nitrogen. 
Proteins were extracted from the muscle and subjected to SDS-PAGE followed by 
immunoblotting as described below. The phosphorylated form of exogenous β-CaMKII 
was identified based on its molecular weight (60.4 kDa), which is very similar to that of 
δa (60.1 kDa), the second largest CaMKII isoform in skeletal muscle (Bayer et al., 
1998).  
 
In situ contraction protocol 
Optimum length of the muscle-tendon complex (the length of the muscle-tendon 
complex at which maximum force was produced) for isometric contractions was first 
estimated using twitches, then determined using a protocol consisting of two twitches 
and one tetanic contraction (pulse duration 100 µsec, tetanic stimulation frequency: 100 
Hz, train duration: 400 ms (De Haan et al., 1993)). Muscles were kept below slack 
length between contractions and rest duration between maximal contractions was 
approximately one minute. After determination of optimum length, muscles rested for 
five minutes. A high-intensity contraction protocol (stimulation frequency: 100Hz; train 
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duration: 300 ms, one train every 800 ms) was then applied to induce muscle fatigue (50 
tetanic contractions, duration: 300 ms, rest interval: 500 ms) with muscles set to 
optimum length. GM and SOL were dissected after the end of stimulation and snap-
frozen in liquid nitrogen. Animals were killed by intra-cardiac injection of Euthasol®, 
while still fully anaesthetised. Frozen muscles were stored at -80ºC until used for 
western blot, immunohistochemical and RT-PCR analysis as described below.  
Force traces collected during muscle stimulation were analysed using custom 
written software based on Matlab (v 7.5.0., The Mathworks Inc., MA, USA). Time to 
peak twitch force (TTP), half-relaxation time (HRT), maximum active twitch force (Ftw) 
and active maximum tetanic force (Fmax) (total force minus passive force) were 
determined. The same contraction parameters were determined for a group of non-
transfected muscles (NTm; SOL/GM n=8). Values obtained for the two twitch values in 
each trace were averaged. 
 
Protein biochemistry 
Western blotting 
To analyse protein expression, frozen 25 µm thick cross-sections taken from the centre 
portion of the muscle were homogenised in ice-cold RIPA buffer (50mM TRIS-HCl 
(pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% v/v Nonidet P40 substitute, 0.25% w/v 
sodium deoxycholate) plus freshly added protease/phosphatase inhibitors: 1 mM NaF, 1 
mM Na3VO4, 0.1 mM PMSF, 1 µg/ml leupeptin, 0.2 µg/ml pepstatin, 0.1 µg/ml 
aprotinin, all from Sigma-Aldrich, Dorset, UK) using a Polytron homogeniser 
(Kinematica, Luzern, Switzerland). Crude homogenates were aspirated 5-10 times 
through a 0.8 mm syringe needle, and stored at -80ºC until use for analysis. An aliquot 
of the aspirated homogenate was taken for determination of protein concentration with 
the bicinchoninic acid protein assay (Pierce, Rockford IL, USA). 
Protein levels of total CaMKII and phospho
Thr287
-CaMKII were analysed by 
western blotting followed by immunodetection. Homogenates were denatured by 
addition of SDS-PAGE buffer (final concentration: 50 mM TRIS-HCl (pH 6.8), 2% w/v 
SDS, 2% w/v bromophenol blue, 10% v/v glycerol, 2% β-mercaptoethanol) and five 
minutes heating at 95ºC. 20-40 µg of protein was separated by SDS-PAGE and 
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transferred overnight onto a nitrocellulose membrane (GE Healthcare, Little Chalfont, 
UK). Membranes were stained with Ponceau S solution to confirm equal protein loading 
and transfer. The membrane was blocked in 5% skimmed milk in TRIS-buffered saline 
(pH 7.4) with 0.05% tween-20 (TBS-T), followed by  incubation with a primary 
antibody for either pan-CaMKII (BD Bioscience #611292, dilution: 1/2500), 
phospho
Thr287
-CaMKII (Cell Signalling Technology #3361, dilution: 1/1000) or COXIV 
(Cell Signalling Technology #4850, dilution: 1/2000) for 2 hours. Antibody incubation 
solutions were 5% milk in TBS-T (for pan-CaMKII) or 5% bovine serum albumin 
(BSA) in TBS-T (for phospho
Thr287
-CaMKII and COXIV). Finally, membranes were 
incubated with species-specific horseradish peroxidase-conjugated secondary antibodies 
(Millipore, Watford, UK). Membranes were washed in TBS-T for 4 x 5 minutes after 
both antibody incubations. Antibodies were detected with an enhanced 
chemiluminescence kit (Pierce, Rockford IL, USA). Light signals were captured with a 
ChemiDoc XRS system (Biorad, Hemel Hempstead, UK).  
Transfected muscle pairs from the same animal were run on the same blot. 
Measures were limited to animals whose CaMKII-transfected muscles showed increased 
expression of the exogenous CaMKII isoforms on a western blot. Protein bands were 
quantified with Quantity One version 4.6.8 (Biorad). For the analysis of COXIV 
protein, a reference muscle sample was run on every blot, and COXIV protein bands 
were standardised to the intensity of this sample. These values were subsequently 
expressed as relative to the mean of the empty-transfected muscles. 
 
In vitro CaMKII phosphorylation 
To detect endogenous and exogenous calcium/calmodulin-sensitive protein bands, 
CaMKII was phosphorylated in vitro by addition of a calcium/calmodulin mixture to 
protein extracts of non-transfected and transfected muscle as described previously 
(Fluck et al., 2000b). Phosphorylated CaMKII was subjected to SDS-PAGE and 
immunoblotted as described. 
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Immunofluorescence & confocal microscopy 
To investigate differences in protein expression at the single fibre level, 
immunofluorescence stains were performed on cryosections of transfected muscles. 
Sections (12 µm thickness) were cut on a cryostat and dried for 30 minutes on glass 
slides. Sections were then fixed with ice-cold acetone and blocked with 5% normal goat 
serum in phosphate buffered saline, pH 7.5 (PBS). CaMKII and COXIV or CaMKII and 
SERCA2 were detected simultaneously using commercially available primary 
antibodies (dilutions: anti-CaMKII: 1/250; anti-COXIV: 1/250, anti-SERCA2 (Abcam 
#Ab3625 or Abcam #2A7-A1): 1/200) as described and species-specific Alexa 488/555 
secondary antibodies (Invitrogen, Paisley, UK). Sections were washed with PBS for 4 x 
5 minutes after both antibody incubations. To detect nuclei, sections were incubated for 
10 minutes with TO-PRO-3 iodide (Invitrogen). Immunolabelled sections were 
embedded in fluorescence compatible mounting medium (DAKO, Ely, UK).  
Protein expression in transfected fibres was analysed on a TCS SP5 confocal 
microscope (Leica, Milton Keynes, UK). A 10x objective was used in combination with 
4x optical zoom. The fluorescent labels were excited with an Argon laser at 488nm and 
HeNe lasers at 543 nm and 633 nm. The pinhole was set to match the thickness of the 
stained section and the focus plane was adjusted to maximise signal detection. Dyes 
were excited separately using a sequential scanning mode. Detected light spectra were 
set to maximise signal detection, but care was taken to prevent cross-excitation of dyes. 
Laser intensity was set to produce images with few under- or overexposed pixels, and 
low levels of non-specific staining, as indicated by light emission from sections that had 
been labelled with the secondary antibodies only. 8-Bit images were captured at 2048 x 
2048 pixels, using 100 Hz scanning speed and 5 times line averaging.            
COXIV staining in CaMKII-transfected muscle fibres (identified based on 
CaMKII staining intensity by visual inspection) was quantified with ImageJ 
(rsbweb.nih.gov/ij/). Fibres were circumscribed manually and the average pixel intensity 
within the fibre was measured. An approximately equal number of non-transfected 
fibres in the same image was measured as well, and acted as the control group of fibres 
to which the transfected fibres were compared. 
 
56 
 
RT-PCR  
RNA extraction from muscles and RT-PCR analysis were carried out as described 
elsewhere (van Wessel et al., 2010). Total RNA was extracted from frozen 25 µm 
sections of transfected muscles using the RiboPure kit (Applied Biosystems). RNA 
concentration and purity (260/280 nm ratio; mean: 2.06, range: 1.92-2.09) were 
determined using a spectrophotometer (Nanodrop Technologies, Wilmington, DE). 
Total RNA concentration in muscle tissue was expressed as RNA (ng) per weight of the 
analysed sample (mg). Five hundred nanogram of total RNA per muscle was reverse 
transcribed using the high capacity RNA-to-cDNA kit (Applied Biosystems) containing 
random primers in a 20 µl total reaction volume. Tubes were heated at 25 ºC for 5 min, 
followed by 42 ºC for 30 min. Finally, the tubes were heated to 85ºC for 5 min to stop 
the reaction and stored at -80 ºC until used in the PCR reaction.  
For each PCR target, 5 µl of the RT reaction product was amplified in duplicate 
using Fast Sybr Green mastermix (Applied Biosystems). The following transcripts were 
targeted: 18S ribosomal RNA (18S rRNA), cytochrome-c oxidase subunit 1 (COXI), 
cytochrome-c oxidase 4 (COXIV), succinate dehydrogenase subunit b (SDHb), 
peroxisome proliferator-activated receptor gamma-coactivator 1 alpha (PGC-1α) and 
SERCA2a. PCR primers were designed using Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Primer sequences and Genbank 
accession numbers for the transcripts are shown in table 1. Amplification efficiency of 
the primers used was 92.7-102.0%, and melting curve analysis demonstrated specific 
amplification. The range of cycle threshold values was 13-25. For 18S rRNA, mean 
cycle threshold values were converted into relative concentrations by 2
-Ct
. For all other 
transcripts, 18S rRNA cycle threshold was subtracted from the mean cycle threshold 
value of the specific target to obtain ∆Ct and converted into relative concentrations by 2
-
∆Ct
.      
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Target mRNA PCR primer sequence 5’→ 3’ 
 
Genbank Accession nr. 
18S RNA Forward: CGAACGTCTGCCCTATCAACTT   EU 139318.1 
 Reverse: ACCCGTGGTCACCATGGTA     
COXI Forward: TGCCAGTATTAGCAGCAGGT X14848.1 
 Reverse:  GAATTGGGTCTCCACCTCCA  
COXIV (isoform 1) Forward: AGTCCAATTGTACCGCATCC 
NM 017202.1 
 Reverse:  ACTCATTGGTGCCCTTGTTC  
SDH (subunit b) Forward: CAGAGAAGGGATCTGTGGCT NM 001100539.1 
 Reverse:  TGTTGCCTCCGTTGATGTTC  
PGC-1α Forward: ATGAGAAGCGGGAGTCTGAA NM 031347.1 
 Reverse: GCGCTCTTCAATTGCTTTCT  
SERCA2a Forward: GGCCCGAAACTACCTGGAGCC 
Reverse: CAACGCACATGCACGCACCC 
NM 001110139.2 
  
 
Table 1: Primers sequences used for RT-PCR analysis of mRNA targets 
 
 
Statistics   
Statistical analyses were carried out with SPSS16 (SPSS Inc, IL, USA). 
Immunofluorescence data from non-transfected fibres and CaMKII-transfected fibres in 
the same muscle were analysed with two-tailed paired t-tests. Western blot and RNA 
data from control- and CaMKII-transfected muscles were analysed with two-tailed 
Wilcoxon signed ranks tests. RNA data from non-transfected muscles and control-
transfected muscles were analysed with a Mann-Whitney U-test. Effects of transfection 
on twitch and tetanic force parameters from non-transfected and control-transfected 
muscles were tested with a factorial ANOVA (muscle x transfection). Correlations 
between the increase in CaMKII protein level following transfection and changes in 
COXIV protein, all transcripts and force parameters were tested using Spearman’s rho. 
Non-parametric tests were run with exact significance. Significance level was set at p < 
0.05. 
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Results  
 
Endogenous and exogenous CaMKII expression and phosphorylation in skeletal 
muscle 
In vitro phosphorylation of CaMKII allowed the identification of four Ca
2+
/CaM-
dependent isoforms in rat skeletal muscle. Based on previously published results  (Bayer 
et al., 1998), we identified these bands as the βM, δA, δD and γB CaMKII isoforms (Fig. 
1A). When CaMKII was overexpressed, we detected increased protein levels of α- and 
β-CaMKII isoforms (which have molecular weights of 50 and 60 kDa, respectively) 
compared to control-transfected muscle (Fig. 1B). When homogenate of CaMKII-
transfected muscle was incubated with calcium and calmodulin, increased 
phosphorylation of CaMKII was detected (Fig. 1C). The overexpressed CaMKII was 
localized in the cytoplasm, but not in the myonuclei (Fig. 1D) 
 
 
 
 
 
59 
 
Figure 1: Expression of endogenous and exogenous CaMKII in rat skeletal muscle 
A: Endogenous total CaMKII (top panel) and phosphoThr287-CaMKII (bottom panel) of rat GM 
homogenate after incubation with EGTA (left) or Ca2+/Calmodulin (Ca2+/CaM). CaMKII 
isoforms were identified based on data from (Bayer et al., 1998). B: Representative western blot 
image demonstrating overexpression of the exogenous α (50kDa) and β (60kDa) CaMKII 
isoforms in m. gastrocnemius medialis (GM) and m. soleus (SOL). Note that skeletal muscle 
expresses endogenous isoforms with molecular weights of 72 and 57-60 kDa (Bayer et al., 1998). 
CON: Control-transfected muscle; CaMKII: CaMKII-transfected muscle. C: Total CaMKII (top 
panel) and phosphoThr287-CaMKII (bottom panel) of α/β-CaMKII-transfected m. soleus 
homogenate after incubation with EGTA or Ca2+/CaM. D: Immunofluorescence image 
demonstrating non-nuclear localisation of overexpressed CaMKII (red) in skeletal muscle fibres. 
Example CaMKII-transfected (Tf) and non-transfected fibres in the same muscle (NTf) are 
marked in the images by white letters. Nuclei are stained in blue. White arrows point to 
representative nuclei of transfected fibres. Green arrows point to central nucleus in transfected 
fibre, indicating regeneration. 
 
 
We assessed phosphorylation of endogenous and exogenous CaMKII after a 
two minute isometric contraction protocol. In contrast to a previous study (Rose et al., 
2007a), we did not observe a consistent increase in phosphorylation of the endogenous 
CaMKII isoforms after the two minute isometric protocol (GM: n=6; SOL: n=6; Fig. 2). 
However, in a number of stimulated muscles, we observed increased phospho-CaMKII 
with the molecular weight of exogenous β-CaMKII (see arrows in Fig. 2).  
 
 
 
Figure 2: Phosphorylation of exogenous CaMKII in rat skeletal muscle in situ 
Total CaMKII (top panel) and phosphoThr287-CaMKII in transfected m. gastrocnemius medialis 
(GM) and m. soleus (SOL). Endogenous and exogenous (bold) CaMKII isoforms are labelled. 
Red arrows indicate phosphoylated exogenous β-CaMKII in Stim-labelled lanes. Rest: non-
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stimulated muscle. Stim: muscle subjected to in situ stimulation (with stimulation frequency as 
indicated below the blots). 
 
 
Gene transfer-induced regeneration  
The presence of small fibres, fibres with central nuclei, and the accumulation of nuclei 
outside the fibres in transfected muscles indicated that these muscles were undergoing 
regeneration after gene electrotransfer (Fig. 1D). The gene transfer procedure also 
increased the concentration of total RNA in muscle tissue (non-transfected muscle: 284 
ng/mg tissue; control-transfected muscle: 708 ng/mg, p<0.01; Fig. 3). However, there 
was no difference in RNA concentration between control- and CaMKII-transfected 
intra-animal pairs (708 ng/mg vs. 735 ng/mg, p=0.81; Fig. 3A). 
 
CaMKII is not sufficient to increase mitochondrial gene expression  
RT-PCR was used to investigate whether CaMKII overexpression increased transcript 
levels of components of the oxidative phosphorylation chain encoded by either nuclear 
(SDHb, COXIV) or mitochondrial (COXI) DNA, and the transcriptional co-factor PGC-
1α which, when overexpressed, increases mitochondrial biogenesis (Wu et al., 1999). 
This analysis was limited to SOL, because of the higher transfection efficiency achieved 
in this muscle. Seven muscle samples were selected for analysis based on exogenous 
CaMKII expression level. 18S rRNA content did not differ between control- and 
CaMKII-transfected muscles (Fig. 3B), and was used as an internal reference for the 
other transcripts. SDHb mRNA level was lower in CaMKII-overexpressing muscles (-
26%, p=0.04), with no significant differences in transcript levels of COXIV, COXI or 
PGC-1α (Fig. 3C-F). No correlation was observed between the degree of CaMKII 
overexpression and the difference in transcript level for any of the transcripts.  
 
To test whether overexpression of  CaMKII was sufficient to increase COXIV 
protein expression in GM and SOL, cryosections of transfected muscles were co-stained 
for CaMKII and COXIV (Fig. 4A). COXIV staining intensity as measured by 
immunofluorescence in individual fibres of transfected muscles did not differ between 
CaMKII-overexpressing and non-transfected fibres of both GM (non-transfected: n=51, 
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transfected: n=54; p=0.91) and SOL muscle (non-transfected: n=35, transfected: n=38; 
p=0.38) (Fig. 4A/B).   
 
 
Figure 3: Effects of CaMKII transfection on mitochondrial gene transcript levels 
A: Concentration of total RNA in transfected and non-transfected muscles. B-F: relative 
concentrations of indicated transcripts in control and CaMKII-transfected m. soleus. Bars indicate 
mean data. Raw data are plotted as symbols and lines indicate intra-animal pairs. Same symbols 
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indicate measurements on the same muscle. Significance of control- vs. CaMKII-transfected 
differences is indicated. NTm: Non-transfected muscle; Control: reporter only transfected; 
CaMKII: reporter + α/β-CaMKII transfected.    
 
 
 
 
 
Figure 4: COXIV protein expression in CaMKII-transfected fibres  
A: Immunofluorescence images of transfected muscle fibres of m. gastrocnemius medialis (GM) 
and m. soleus (SOL) stained for different proteins as indicated. Black bar indicates 100 µm. B: 
Graphs displaying mean ± S.E.M. pixel intensities of transfected (Tf) and non-transfected (NTf) 
fibres in GM and SOL. Example Tf and NTf are marked in the images by white letters. 
Significance of NTf vs. Tf differences is indicated. Data are relative to NTf.  
 
 
CaMKII overexpression increases the speed of twitch contraction and relaxation  
CaMKII has been thought to affect calcium release from, and/or calcium re-uptake into, 
the SR. Because twitch contraction and relaxation speed during isometric contractions 
depend mainly on the properties of the SR (see for review Schiaffino, 2010), we 
investigated whether these parameters differed between control- and CaMKII-
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transfected muscles. Both TTP and HRT were higher in control-transfected muscle 
compared to non-transfected muscle (TTP: +22%, p=0.05, main effect; HRT: +32%, 
p=0.03, main effect; Fig. 5). We observed a significant decrease in TTP and HRT in 
CaMKII-transfected muscles compared to control-transfected muscles (TTP: -16%, 
p=0.02, main effect; HRT: -15%, p=0.04, main effect; Fig. 5).  
 
 
 
Figure 5: Effects of CaMKII overexpression on twitch contraction/relaxation time 
A: m. soleus (SOL) time-to-peak twitch force (TTP); B: m. gastrocnemius medialis (GM) TTP; C: 
SOL twitch half relaxation time (HRT); D: GM twitch HRT. Bars indicate mean data. Raw data 
are plotted as black dots for non-transfected muscles and as symbols for transfected muscle pairs. 
Lines indicate intra-animal pairs and symbols indicate measurements on the same muscle. NTm: 
Non-transfected muscles; Control: reporter only-transfected muscles; CaMKII: reporter + α/β-
CaMKII-transfected muscles. a Main effect of gene  transfer on TTP (p<0.05); b Main effect of 
CaMKII overexpression in TTP (p<0.05); c Main effect of gene transfer on HRT (p<0.05); d Main 
effect of CaMKII overexpression on HRT (p<0.05). 
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SERCA2 protein expression increases in CaMKII overexpressing m. soleus fibres 
We investigated whether the observed reduction in HRT might be due to increased 
expression of the SERCA2 isoform. Examples of immunofluorescence 
CaMKII/SERCA2 co-stained m. soleus fibres are shown in figure 6A. SERCA2 staining 
intensity in CaMKII-overexpressing m. soleus fibres was significantly higher compared 
to that in non-transfected fibres of the same muscle (non-transfected: n=221, 
transfected: n=276; p<0.001; Fig. 6B). Identical results were obtained when the staining 
was repeated with a different anti-SERCA2 antibody. 
 
 
 
Figure 6: CaMKII overexpression increases SERCA2 expression in m. soleus fibres 
A: Example immunofluorescence images of m. soleus fibres stained for different proteins as 
indicated above the image. Bar indicates 100 µm.  B: Graphs displaying mean ± S.E.M. pixel 
intensities of transfected (Tf) and non-transfected (NTf) fibres in GM and SOL. Example Tf and 
NTf fibres are marked in the images by white letters. Significance of NTf vs. Tf differences is 
indicated. Data are relative to NTf.  
 
 
 We used RT-PCR to investigate whether CaMKII overexpression increased SERCA2 
transcript levels. Primer sequences for primers targeting the SERCA2a isoform, which 
is the predominant SERCA isoform in normal rat m. soleus (Zador et al., 1996), are 
shown in table 1. We did not observe an increase in SERCA2a mRNA in CaMKII-
transfected compared to control-transfected m. soleus (Fig. 7). Rather, a trend for a 
down-regulation was apparent.  
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Figure 7: Effect of CaMKII-overexpression on SERCA2a transcript level in m. soleus fibres. 
Graph displays the relative transcript concentration in control and CaMKII-transfected m. soleus. 
Bars indicate mean data. Raw data are plotted as symbols (the same as Fig. 4) and lines indicate 
intra-animal pairs. Same symbols indicate measurements on the same muscle. Significance of 
control- vs. CaMKII-transfected differences is indicated. 
 
 
CaMKII overexpression does not increase maximum force and fatigue resistance  
Gene electro-transfer caused a decrease in maximal tetanic force (p<0.001, main effect), 
which was larger in SOL (-49%) than in GM (-14%) (Fig.8). Maximum twitch force 
was also reduced (p=0.03, main effect), but this reduction was of a lower magnitude 
compared to the reduction in maximal tetanic force (SOL: -18%; GM: -7%) (Fig.8). 
Both maximum tetanic and maximum twitch force did not differ between control- and 
CaMKII-transfected muscles. Finally, we observed no difference in fatigue resistance 
between control- and CaMKII-transfected GM during 50 repeated tetanic contractions 
(Fig. 9). 
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Figure 8: Maximum twitch and tetanic force of transfected and non-transfected muscles  
Top left: m. soleus (SOL) twitch force (Ftwitch); Top right: m. gastrocnemius medialis (GM) twitch 
force; Bottom left: SOL tetanic force (Fmax); Bottom right: GM tetanic force. Bars indicate mean 
data. Raw data are plotted as black dots for non-transfected muscles and as symbols for 
transfected muscle pairs. Lines indicate intra-animal pairs and symbols indicate measurements on 
the same animal. NTm: Non-transfected muscles; Control: reporter only-transfected muscles; 
CaMKII: reporter + α/β-CaMKII-transfected muscles. a Main effect of gene  transfer on Ftwitch 
(p<0.05); b Main effect of gene transfer on Fmax  (p<0.001). 
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Figure 9: Effects of CaMKII overexpression on force reduction during repeated maximal 
tetanic contractions of GM 
Graph displays tetanic force of m. gastrocnemius medialis (GM) during a contraction protocol 
consisting of 50 repeated tetanic contractions. Maximal tetanic force (mean ± S.E.M.) of every 
fifth contraction is shown. NTm: Non-transfected muscles; Control: reporter only-transfected 
muscles; CaMKII: reporter + α/β-CaMKII-transfected muscles.  
 
Discussion 
 
This is the first study that investigates whether manipulation of CaMKII expression 
affects skeletal muscle phenotype in vivo. In contrast to our hypothesis, we did not 
observe an increase in expression of genes related to mitochondrial biogenesis. 
However, twitch contraction and relaxation times were reduced in CaMKII-transfected 
muscles while SERCA2 protein levels in CaMKII-transfected muscle fibres were 
increased. Our results suggest the involvement of CaMKII in the regulation of the 
contraction-related phenotype, rather than mitochondrial biogenesis. 
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Technical considerations  
Muscle damage and subsequent regeneration are inherent to gene electro-transfer, and 
this enhances the plasticity of the muscle. In myotoxin-induced muscle regeneration 
mitochondrial enzyme expression is decreased, and recovers from day 3 onwards 
(Duguez et al., 2002). The increase in total RNA concentration in control-transfected 
muscles compared to non-transfected muscles in the present investigation (Fig. 3) was at 
least in part due to an increase in 18S rRNA (relative 18S rRNA levels, corrected for 
RNA concentration: NTm: 1.00±0.13; Control-transfected: 3.19±0.62; p<0.01), 
suggesting a higher ribosomal content and translational capacity in these muscles. 
Therefore, we propose this model is sensitised to stimuli that affect the muscle 
phenotype. 
The influence of the gene electro-transfer procedure per se does not affect the 
results of the comparison between transfected and non-transfected fibres, as these were 
located in the same region of the muscle (Fig. 4A & 6A), and both groups consisted of 
relatively small, regenerating fibres which were size-matched between the groups and 
displayed central nuclei.  
Increasing total protein level of native CaMKII in skeletal muscle results in 
potentially higher CaMKII activity which is still amenable to physiological regulation. 
In cardiac myocytes, overexpressing native CaMKII has effects on both functional 
characteristics and the expression of genes involved in excitation-contraction coupling 
and cardiac hypertrophy (Ramirez et al., 1997, Ronkainen et al., 2011). Our results 
suggest that exogenous CaMKII can be activated in skeletal muscle during muscle 
recruitment in vivo (Fig. 2). It is possible that increasing the physical activity of the rats 
in the period after the transfection procedure would have enhanced the effects of the 
overexpressed wild-type CaMKII because of increased recruitment of GM and SOL. It 
has been estimated that motor units in the soleus muscles of caged, but freely moving 
rats are active for 25-30% of a 24- hour period (Hennig and Lomo, 1985). Furthermore, 
rat SOL is recruited during postural and slow running activity (Gorassini et al., 2000). 
Therefore, we expected transfected fibres in this muscle to be frequently recruited. GM 
has been shown to be moderately activated during postural and slow running tasks and 
to be increasingly recruited during running at higher speeds (Gorassini et al., 2000). It is 
therefore possible that the exogenous CaMKII in transfected GM fibres was not 
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sufficiently activated during normal cage activity for CaMKII activity-dependent effects 
on mitochondrial protein expression to manifest.  
 
CaMKII overexpression affects twitch contraction and relaxation speed  
Twitch contraction and relaxation times of CaMKII-overexpressing muscles were 
reduced compared to control-transfected muscles (Fig.5). This is consistent with 
CaMKII-dependent phosphorylation-induced increases in SERCA2 and RyR activities 
in vitro (Hawkins et al., 1994, Xu and Narayanan, 1999, Dulhunty et al., 2001), and 
with the finding that CaMKII inhibition reduced calcium release in single mouse muscle 
fibres (Tavi et al., 2003). CaMKII is targeted to the SR by binding to membrane-
anchoring protein α-KAP, an α-CaMKII splice variant (Bayer et al., 1998). In skeletal 
muscle fibres, overexpressed α-KAP localises mostly to the longitudinal SR (Nori et al., 
2003), where the sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCA) is situated. 
Furthermore, CaMKII is targeted to the junctional SR (Leddy et al., 1993), Therefore, 
CaMKII possibly has access to SERCA and RyR and could increase their activities 
through phosphorylation. However, GM expresses mainly the SERCA1 isoform that 
cannot be phosphorylated by CaMKII (Hawkins et al., 1994), and inhibitory effects of 
CaMKII on RyR activity have also been reported (Wang and Best, 1992). Therefore, it 
is unclear if CaMKII-dependent phosphorylation of SERCA and RyR played a role in 
decreasing twitch contraction and relaxation times in our study.  
Because the contraction experiments were carried out seven days after 
transfection, it is possible that structural adaptations occurred that decreased TTP and 
HRT. As mentioned, transfected fibres appear in a regenerating region of the muscle. If 
we assume that the observed increases in relaxation/contraction times in control-
transfected muscles compared to those in non-transfected muscles are due to changes in 
muscle properties in this region, it becomes apparent that most of the effect of the gene 
transfer procedure is reversed or mitigated in the CaMKII overexpressing muscles (Fig. 
5). Such adaptations might include increased densities of the RyR and SERCA on the 
SR membrane. Indeed, our data suggested that SERCA2 protein expression was 
increased in CaMKII-transfected m. soleus fibres (Fig. 6), a process which possibly 
contributed to the observed decrease in relaxation time.  
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We observed no significant increase in maximal force production (Fig. 8). This 
might be explained by specific effects of the electroporation-induced damage on muscle 
force characteristics. The gene transfer procedure alone reduced maximal twitch force, 
but maximal tetanic force was more strongly reduced (Fig. 8). Specific force was likely 
also decreased in electroporated muscles. A decreased specific force and an increased 
ratio of twitch force to tetanic force in regenerating rat m. soleus have been shown to be 
associated with the expression of developmental isoforms of EC-coupling proteins  
(Esposito et al., 2007). Therefore, it may be that any increase in Fmax was masked by 
negative effects of muscle damage on EC-coupling.  
 
CaMKII overexpression reduces, rather than increases, mitochondrial gene 
expression  
In contrast to our expectations, we observed no increase in mitochondrial protein 
COXIV (Fig. 4) and fatigue resistance (Fig. 9) in CaMKII-overexpressing muscles 
compared to control-transfected muscles. To the best of our knowledge, this is the first 
study investigating whether CaMKII increases the expression of a mitochondrial protein 
in any tissue type. 
Constitutively active CaMKIV increases mitochondrial biogenesis when overexpressed 
from an embryonic stage onward (Wu et al., 2002), but this CaMK is not endogenously 
expressed in skeletal muscle (Akimoto et al., 2004, Rose et al., 2006) and CaMKIV 
knock-out mice do not display altered muscle adaptation in response to training 
(Akimoto et al., 2004). Whether CaMKIV would have a similar function in skeletal 
muscle compared to CaMKII is questionable, since the two proteins have different 
substrate specificity and intracellular localisation (Sun et al., 1996, Srinivasan et al., 
1994, Sun et al., 1994).  
The absence of a difference in fatigue resistance between control- and 
CaMKII-transfected muscles might be due to the muscle oxidative capacity not being 
the limiting factor in the synthesis of ATP under full anaesthesia. Our repeated 
contraction protocol almost certainly required a significant contribution of oxidative 
metabolism to ATP synthesis (Westra et al., 1988), but if blood flow to the working 
muscle was insufficient to meet the increased demand for oxygen, differences in 
oxidative capacity of the muscles may be masked. 
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Our finding that CaMKII overexpression did not increase COXIV protein 
expression was confirmed at the mRNA level. Furthermore, transcript levels of other 
key genes involved in mitochondrial biogenesis were either not significantly changed or 
decreased (Fig. 3). This absence of increased gene expression is in accordance with 
experiments demonstrating that acute inhibition of CaMKII in vivo in mice did not 
affect GLUT4 protein expression (Witczak et al., 2010). The results demonstrate that 
CaMKII is not sufficient to increase mitochondrial gene expression, but do not rule out 
the possibility that it is required for the response to exercise. The idea that CaMKII 
signalling acts in conjunction with other signalling pathways is supported by the 
observation that the activity of a GLUT4-enhancer in mouse tibialis anterior muscle is 
only decreased when CaMKII is co-inhibited with either AMPK or calcineurin (Murgia 
et al., 2009). 
 
Conclusion 
Our results support a role for CaMKII in the regulation of muscle contraction and 
SERCA2 expression, but not in increasing mitochondrial biogenesis. The fact that these 
observations were made after an in vivo intervention in whole muscle is significant in 
the context of current literature on CaMKII function in ex vivo or in vitro systems.          
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Abstract 
 
The effect of CaMKII overexpression on the transcriptional activity of one of its 
potential target genes, skeletal alpha-actin (SKAA) was investigated. The luciferase 
gene controlled by a SKAA promoter fragment was transfected into m. soleus (SOL) 
and m. gastrocnemius (GM) of both hindlimbs of three month-old female wistar rats 
(n=13). CaMKII was overexpressed in SOL and GM of the right leg only. Luciferase 
activity measured in protein extracts of the transfected muscles seven days after 
transfection was significantly lower in SOL (p=0.02) and GM (p=0.04) of the CaMKII-
transfected leg. SKAA mRNA level tended to be lower in the CaMKII transfected leg, 
but this was not significant. We conclude that CaMKII overexpression has a negative 
effect on SKAA gene transcription, but the mechanisms underlying this effect require 
further investigation.   
  
75 
 
Introduction 
 
Repeated high mechanical loading of skeletal muscle typically results in hypertrophy, 
which requires an increased net synthesis of contractile proteins actin and myosin. 
Overloading of chicken muscle by attaching weights to the wing increases the activity 
of the skeletal alpha-actin (SKAA) gene promoter in the m. anterior latissimus dorsi 
(Carson et al., 1995). The serum response element SRE1 in the promoter of the SKAA 
gene, which is bound by the serum response factor (SRF), is necessary and sufficient to 
induce the loading-dependent increase in SKAA promoter activity (Carson et al., 1996). 
However, the upstream mechanisms regulating this promoter activity are not completely 
understood.  
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a candidate to 
transduce increased muscle recruitment into changes in SKAA expression. 
Ca
2+
/calmodulin-independent CaMKII activity and SRF phosphorylation are both 
increased after chronic overload of chicken muscle and knee extension-endurance 
training in humans (Fluck et al., 2000b, Rose et al., 2007b). Phosphorylation of SRF at 
Ser103 increases its binding to serum response elements (Rivera et al., 1993), while 
phosphorylation at Thr160 inhibits this binding (Wheaton and Riabowol, 2004). 
CaMKII can phosphorylate SRF at both Ser103 and Thr160 (Fluck et al., 2000a). 
Because there is a positive association between CaMKII activity and SRF binding to the 
SKAA promoter after high muscle loading, we hypothesised that CaMKII 
overexpression would increase the activity of the SKAA promoter, and SKAA mRNA 
level in rat skeletal muscle. To test this hypothesis, we introduced a SKAA-promoter 
construct containing three functional SRE elements into muscles of the right and left 
hind limbs of rats. CaMKII was overexpressed in the right leg only. To test whether 
CaMKII-dependent regulation depends on fibre type, we used fast-twitch m. 
gastrocnemius and slow-twitch m. soleus for these experiments. 
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Methods  
 
Ethical approval 
A total of 13 female Wistar rats were used for the experiments described here. In situ 
contraction protocols and the majority of the transfections were carried out at the 
MOVE Research Institute Amsterdam, VU University Amsterdam, The Netherlands and 
approved by the local Animal Experiments Committee. Two transfection experiments 
were carried out at the Department of Cardiovascular Surgery, University Hospital 
Bern, Switzerland and approved by the animal protection commission of the Canton of 
Berne, Switzerland. 
 
Somatic overexpression of CaMKII and a skeletal alpha-actin reporter gene  
Plasmids 
PCDNA3 plasmids encoding full-length cDNA for CaMKIIα and CaMKIIβ were a gift 
from Dr. M Neal Waxham (University of Texas, Houston, USA). PGL2 plasmid 
encoding full-length luciferase under control of 424basepairs upstream of the 
transcription start site of the chicken SKAA gene (SKAA-424) (Marsh et al., 1998) was 
a gift from Dr. Frank W. Booth (University of Missouri, Columbia, USA).  This 
promoter construct contains three serum response elements, two Sp1 binding elements, 
one E Box, one MCAT and one TATA Box as described previously (Carson et al., 
1995). These regulatory elements are conserved across species (Ordahl and Cooper, 
1983). 
 
Transfection  
Three month-old female Wistar rats (n=13; Harlan Laboratories and Charles River; 
body weight: 191-230 grams) were used to overexpress CaMKII in m. gastrocnemius 
medialis (GM) and m. soleus (SOL). The animals were anaesthetised with 2-4% 
isoflurane through inhalation. Hind limbs were shaved, and skin was disinfected with 
70% ethanol. An incision was made into the skin and fascia between GM and m. tibialis 
anterior. SOL was subsequently exposed and liberated, after which four injections of 
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plasmid mixture with a total volume of 90 µl were administered intramuscularly using a 
29-gauge insulin syringe. GM was administered four injections over the length of the 
muscle with a total volume of 180 µl. A mix of expression plasmid for full-length 
CaMKIIα (pCDNA3-CaMKIIα; 0.22 µg/µl) and full-length CaMKIIβ (pCDNA3-
CaMKIIβ; 0.22 µg/µl) in Tris-Borate-EDTA buffer was injected into muscles of the 
right leg together with the SKAA-424 reporter plasmid (0.55 µg/µl). Muscles of the left 
leg were injected with the reporter plasmid only (1 µg/µl). Right and left transfected 
muscles will henceforth be referred to as ‘CaMKII-transfected’ and ‘control-
transfected’, respectively. DNA injection was followed by electroporation with a 
GET42 electropulser (E.I.P. Electronique et Informatique du Pilat, Jonzieux, France). 
Needle electrodes were placed along SOL or into GM and pulse protocols were applied 
as described previously (Durieux et al., 2009). 
After electroporation, the skin wound was closed with sutures, and the animal 
was allowed to recover from anaesthesia. Animals were kept in cages individually 
afterwards, where they resumed normal activity within hours after surgery. After seven 
days, animals were anaesthetised with 12.5% urethane to measure muscle contractile 
parameters as described in chapter 3.Transfected muscles were harvested from both legs 
of anaesthetised rats and snap-frozen in liquid nitrogen. The rats were killed afterwards 
by an intra-cardiac injection of Euthasol® while under full anaesthesia.  
 
Luciferase reporter assay 
Frozen muscle samples were homogenised in RIPA buffer as described for western 
blots in chapter 3. Homogenates were centrifuged at 10000 RPM for 10 minutes at 4ºC. 
The supernatant was collected and stored at -80ºC. Protein concentration was 
determined with the BCA method (Pierce, Rockford IL, USA). To assay luciferase 
activity, 20 µg of protein was added to a reaction mix (tricine (2 mM, pH 7.8); MgCl2 (5 
mM), EDTA (2 mM), dithiothreitol (33.3 mM), ATP (0.25 mM), Coenzyme A (0.27 
mM and firefly luciferin (Promega; 0.47mM)) in a white 96-well plate (Eppendorf, 
Stevenage, UK) at a final volume of 100 µl. Light production was measured with a 
Hidex Chameleon Plate reader (Hidex; Turku, Finland) for 10 minutes, and the 
maximum emission ( photon counts per second) was taken as a measure of luciferase 
activity. Measurements were performed in triplicates and intra-animal muscle pairs were 
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always assayed simultaneously. A reference protein sample from a luciferase-expressing 
muscle was always run alongside the experimental samples to check the reproducibility 
of the luciferase measurements.  
 
RNA isolation and RT-PCR 
RNA extraction and RT-PCR analysis were carried out as described elsewhere (van 
Wessel et al., 2010). Total RNA was extracted from frozen 25 µm sections of 
transfected muscles using the RiboPure kit (Applied Biosystems). RNA concentration 
and purity (260/280 nm ratio; mean: 2.06, range: 1.92-2.09) were determined using a 
spectrophotometer (Nanodrop Technologies, Wilmington, DE). Five hundred nanogram 
of total RNA per muscle was reverse transcribed using the high capacity RNA-to-cDNA 
kit (Applied Biosystems) containing random primers in a 20 µl total reaction volume. 
Tubes were heated at 25ºC for 5 min, followed by 42ºC for 30 min. Finally, the tubes 
were heated to 85ºC for 5 min to stop the reaction and stored at -80ºC until used in the 
PCR reaction.  
For each PCR target, 5 µl of the RT reaction product was amplified in duplicate 
using Fast Sybr Green mastermix (Applied Biosystems). 18S ribosomal RNA (18S 
rRNA) and skeletal alpha-actin (SKAA) mRNA were amplified. Primer sequences are 
shown in table 1. Amplification efficiency of the primers used was 94.5-102.0%, and 
melting curve analysis demonstrated specific amplification. The range of cycle 
threshold values was 13-25. For 18S rRNA, mean cycle threshold values were 
converted into relative concentrations by 2
-Ct
. To quantify the SKAA transcript, 18S 
rRNA cycle threshold was subtracted from the mean cycle threshold value of the 
specific target to obtain ∆Ct and converted into a relative concentration by 2
-∆Ct
.      
 
Statistics 
The differences in luciferase activity and SKAA transcript level between control- and 
CaMKII-transfected muscle pairs were tested with a two-sided wilcoxon signed-ranks 
test. Significance was accepted at p<0.05. 
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Target mRNA PCR primer sequence 5’→ 3’ 
 
GenBank accession nr 
18S RNA Forward: CGAACGTCTGCCCTATCAACTT   EU 139318.1 
 Reverse: ACCCGTGGTCACCATGGTA     
SKAA Forward: CGACATCGACATCAGGAAGGA  NM 019212.2 
 Reverse: GGTAGTGCCCCCTGACATGA  
 
Table 1: Primers sequences used for RT-PCR analysis of mRNA targets 
 
Results 
 
Luciferase activity was significantly lower in CaMKII-transfected SOL and GM (Figure 
1A), indicating that SKAA promoter activity had been lower in these muscles. In 
accordance with the lower promoter activity, SKAA transcript levels tended to be lower 
in CaMKII-transfected m. soleus (Figure 1B), but this was not significant.  
 
 
Figure 1: Effects of CaMKII overexpression on SKAA promoter activity and mRNA level 
A). Luciferase activity (in photon counts per second, CPS) in 20 µg of protein homogenate of 
CaMKII+SKAA-424-luciferase-transfected muscles (CaMKII) and SKAA-424-luciferase-
transfected only (Control) muscles. SOL: m. soleus. GM: m.gastrocnemius. B). SKAA mRNA 
level normalized to 18S rRNA in CaMKII+SKAA-424-luciferase-transfected (CaMKII) and 
SKAA-424-luciferase-transfected only (Control) m. soleus. Dots indicate individual 
measurements, and dashed lines connect measurements on intra-animal muscle pairs. Statistical 
significance of the comparison between Control- and CaMKII-transfected muscles is indicated 
above the bars. SKAA: skeletal alpha-actin.      
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Discussion 
 
 In contrast to our expectations, SKAA promoter activity in CaMKII-transfected 
muscles was decreased rather than increased compared to control-transfected muscles, 
and SKAA mRNA tended to be decreased in CaMKII-transfected muscles. 
What might be the explanation for our observation that SKAA-424 promoter activity is 
decreased with CaMKII overexpression, regardless of fibre type? CaMKII can 
phosphorylate SRF at two sites at least, Ser103 and Thr160 (Fluck et al., 2000a). 
Phosphorylation at Ser103 increases its binding to the serum response element (Rivera 
et al., 1993), while phosphorylation of SRF at Thr160 inhibits binding to the SRE 
(Wheaton and Riabowol, 2004). Therefore, a possible explanation for our results is that 
CaMKII overexpression increased SRF phosphorylation at Thr160, which reduced SRF 
binding to the SRE and the expression of the SKAA -424 promoter-dependent luciferase 
activity. 
 
Is it possible that CaMKII activates another pathway with inhibitory effects on SKAA 
gene expression? CaMKII can affect the transcription of multiple genes through 
phosphorylation of histone deacetylase 4 (HDAC4) (Backs et al., 2006). However, 
phosphorylation of HDAC4 releases HDAC4-mediated inhibition of SRF-activated 
transcription of a SKAA-reporter gene (Davis et al., 2003), and would thus be expected 
to increase, rather than decrease, SKAA promoter activity and transcription. CaMKII 
also phosphorylates H1 histone in vitro (Woodgett et al., 1983), but phosphorylated H1 
histone is also associated with increased, rather than decreased transcriptional activity 
(Zheng et al., 2010). In conclusion, no pathway is known through which CaMKII can 
inhibit SKAA gene expression. 
 
If CaMKII only activates pathways that stimulate gene expression, as discussed above, 
perhaps overexpression of CaMKII somehow inhibited this positive effect on gene 
transcription. The intracellular localisation of overexpressed CaMKII has been shown to 
be important for the CaMKII-dependent effect on gene transcription in other cell types. 
In ventricular cardiomyocytes, nuclear-targeted CaMKII was required to activate 
transcription of the atrial natriuretic factor (ANF) (Ramirez et al., 1997). However, 
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nuclear CaMKII isoforms were depleted from the nucleus by overexpression of 
cytosolic isoforms which do not contain a nuclear localisation sequence (NLS), and this 
prevented ANF transcription. This phenomenon has also been observed in fibroblasts 
where nuclear or cytosolic targeting depended on the expression ratio of CaMKII 
isoforms containing an NLS and CaMKII isoforms that do not (Srinivasan et al., 1994). 
The α/β-CaMKII isoforms used in the present study do not contain a NLS and were 
localised to the cytoplasm and excluded from the nucleus of transfected fibres (Chapter 
3). In nuclear extracts of non-transfected chicken skeletal muscle, CaMKII activity has 
been measured  (Fluck et al., 2000a) which raises the possibility that α/β-CaMKII 
overexpression had an inhibitive effect on gene expression similar to that observed in 
cardiomyocytes. However, the CaMKII isoforms thought to be expressed in skeletal 
muscle do not contain a nuclear localisation sequence (Bayer et al., 1998). This suggests 
that nuclear targeting of these isoforms might depend on the anchoring protein α-KAP 
(Nori et al., 2003), and that factors other than the ratio of nuclear and cytosolic CaMKII 
isoforms expressed are important in determining whether CaMKII is localised to the 
nucleus. In conclusion, it is unclear whether CaMKII can be depleted from the nuclei of 
skeletal muscle fibres by overexpression of cytosolic CaMKII isoforms.  
 
We conclude that CaMKII affects the activity of the SKAA promoter in skeletal muscle, 
but the precise mechanisms underlying this regulation are yet unclear. Future research 
should identify whether manipulation of CaMKII affects SRF phosphorylation, and 
which promoter elements are involved in the CaMKII-dependent regulation in skeletal 
muscle in vivo.  
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Abstract 
 
Calcium/calmodulin-dependent protein kinase II (CaMKII) has been demonstrated to 
modulate calcium release from the sarcoplasmic reticulum and phosphorylate the 
sarco/endoplasmic reticulum Ca
2+
-ATPase in vitro. CaMKII overexpression in skeletal 
muscle in vivo increased twitch contraction and relaxation speed (chapter 3). However, 
it is unclear if CaMKII-dependent modification of RyR and SERCA activity is 
sufficient to explain the increase twitch speed. In addition, it is unclear if CaMKII 
activation is similar throughout the subsarcomeric space or if activation is higher near 
the calcium release sites. To address these questions, we used a mathematical model of 
spatiotemporal sarcomeric [Ca
2+
] dynamics coupled to a biochemical model of CaMKII 
activation. Modelling results were compared to experimental results. The model 
predicted substantial spatial gradients in CaMKII activity in sarcomeres of fast- and 
slow-twitch muscle fibres during single and repeated RyR openings. Increasing the 
CaMKII concentration in the model did not produce faster twitch speeds, which could 
be explained by minimal CaMKII activation during twitch contraction. Experimental 
overexpression of CaMKII increased SERCA2 expression in rat m. soleus muscle fibres 
and this could at least partially explain the observed decrease in twitch relaxation time 
(chapter 3). We conclude that not an increased CaMKII-dependent SERCA activity, but 
increased SERCA protein level underlies the increase in twitch relaxation speed after 
CaMKII overexpression.  
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Introduction 
 
In skeletal muscle, calcium/calmodulin-dependent protein kinase II (CaMKII) is 
presumed to regulate calcium release from, and re-uptake into, the sarcoplasmic 
reticulum (SR) of skeletal muscle fibres through modification of the ryanodine receptor 
(RyR) and the sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCA), respectively. Acute 
pharmacological inhibition of CaMKII has an inhibitory effect on calcium release 
during tetanic contractions of single fast-twitch mouse fibres (Tavi et al., 2003), 
suggesting that CaMKII stimulates opening of the RyR. Furthermore, SERCA 
phosphorylation by CaMKII increases maximal activity of the slow-twitch SERCA 
isoform in isolated SR membranes (Hawkins et al., 1994, Xu and Narayanan, 1999). In 
addition, CaMKII increases SERCA activity by phosphorylating regulatory proteins 
sarcolipin (Bhupathy et al., 2009, Tupling et al., 2011) and phospholamban (MacLennan 
and Kranias, 2003). Finally, CaMKII overexpression in rat skeletal muscle in vivo 
decreased twitch contraction and relaxation times (chapter 3). These findings support 
the idea that the speed of calcium release and re-uptake in muscle fibres can be altered 
via modification of RyR and SERCA by CaMKII.  
 These targets, however, have a specific spatial distribution within a sarcomere. 
RyR is located at the terminal cisternae of the SR (Inui et al., 1987), whereas SERCA is 
located on the longitudinal SR (Jorgensen et al., 1982). It has been demonstrated in 
mouse m. flexor digitorum brevis fibres that the increase in cytoplasmic [Ca
2+
] after a 
single depolarisation depends on the location within a sarcomere, with the largest 
change occurring near the calcium release site, and the smallest changes near the m-line 
(Gomez et al., 2006). As the increase in cytoplasmic [Ca
2+
] is probably essential for 
contraction-induced CaMKII activation, there may also be a substantial gradient in 
CaMKII activity in sarcomeres. This raises the question whether CaMKII can affect 
SERCA, a target which is not in the immediate vicinity of the calcium release site, in 
skeletal muscle fibres.  
 We investigated whether, upon calcium release from the SR, CaMKII is 
activated to a greater extend when it’s located in the vicinity of the RyR and whether 
increasing sarcomeric CaMKII concentration decreases the speed of calcium release 
from and re-uptake into the SR. The complexity of the required measures means that an 
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in vivo approach is unfeasible. We therefore coupled computational models of 
spatiotemporal sarcomeric [Ca
2+
] dynamics in slow-twitch and fast-twitch fibres to 
models of CaMKII activation and RyR/SERCA modulation.    
 
Methods 
 
Description of spatiotemporal calcium dynamics model 
A computational model describing spatiotemporal [Ca
2+
] dynamics in a half sarcomere 
of a fast-twitch mouse muscle (Groenendaal et al., 2008) was extended with a detailed 
biochemical model describing CaMKII activation (Saucerman 2008). Both models 
consist of coupled differential equations and contain no stochastic elements. The code 
for the sarcomeric model was kindly provided by Dr. Willemijn Groenendaal 
(Eindhoven University of Technology, The Netherlands). The sarcomeric model 
describes a cylinder consisting of four radial layers, of which the inner three form the 
myoplasm and the outer layer forms the sarcoplasmic reticulum (SR). Longitudinally, 
the layers are divided into six parts of equal volume, to form 18 myoplasmic elements 
and six SR elements (Fig. 1A). The number of elements in the model was limited to 24 
to prevent excessive computational times and remain within computer memory limits. 
The elements include buffering of calcium by troponin-C, parvalbumin (in fast-twitch 
muscle) and ATP in the myoplasm and calsequestrin in the SR. In the model, calcium is 
able to diffuse within the myoplasm and the SR, and is transported between these two 
compartments through the RyR and SERCA, which have distinct locations on the 
modelled SR (Fig. 1A). 
 Sarcomeres of both fast-twitch (FT) and slow twitch (ST) muscle fibres were 
modelled. Clear structural and biochemical differences exist between these fibre types 
and these were implemented as previously described (Groenendaal, 2011). In 
comparison with the FT model, the ST model has:  
 no parvalbumin 
 a 50% lower SR volume, relative to the volume of the myoplasm. 
 2.4 fold lower maximal RyR activity 
87 
 
 3 fold lower maximal SERCA activity 
 fewer Ca2+ binding sites on troponin 
 1.5 fold higher resting myoplasmic [Ca2+] 
 lower ATP concentration 
 
Extension of calcium model with CaMKII reaction scheme 
To each myoplasmic element in the model, we added a CaMKII reaction scheme 
describing Ca
2+
 binding to calmodulin (CaM) (Fig. 1B) and subsequent binding of Ca
2+
-
CaM to CaMKII (Saucerman and Bers, 2008). Six different fractions of CaMKII exist in 
the model (Fig. 1C): Pi (inactive), Pb2 (Ca2CaM-bound), Pb (Ca4CaM-bound), Pt2 
(Ca2CaM-bound and phosphorylated at Thr287), Pt (Ca4CaM-bound and phoshorylated 
at Thr287) and Pa (unbound and phosphorylated at Thr287). Of these fractions, Pb, Pt2, 
Pt and Pa were assumed to have 100% activity. In the model, CaMKII phosphorylation 
is reversed by protein phosphatase 1 (PP1) (Fig. 1C). 
Some modifications were made to the CaMKII reaction scheme described by 
Saucerman & Bers. We removed CaM-buffering from the model and modelled only free 
CaM. Furthermore, we used different reaction kinetic parameter values for a number of 
reactions, which we found to be more in agreement with available literature (Appendix). 
The absolute concentrations of Pi, Pb, Pb2, Pt, Pt2 and Pa, instead of concentrations 
normalized to total CaMKII concentration, were used to calculate reaction rates. This 
allowed us to investigate the effect of changes in CaMKII concentration on calcium 
dynamics. Isoform-specific parameters for the β-CaMKII isoform were used to describe 
CaM-affinity for CaMKII (Gaertner et al., 2004).  
 CaMKII-dependent modification of SERCA activity was implemented in the 
ST model as previously described for modelled cardiomyocytes (Koivumaki et al., 
2009), while in the FT model regulation of SERCA activity was absent (Hawkins et al., 
1994). In both the FT and the ST model, the RyR parameter 'Power1' was made 
dependent on the level of active CaMKII to prolong opening of the RyR in a similar 
way to that used for a model of cardiomyocytes (Hund and Rudy, 2004) (see Appendix). 
The values of KmMax and DPowermax, which describe how strongly CaMKII activity 
affects the activity of RyR and SERCA (Appendix), were set so that the model could 
reproduce the CaMKII inhibition-induced decrease in calcium release during a 70Hz 
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contraction, which has been previously demonstrated experimentally in single mouse 
fast-twitch muscle fibres (Tavi et al., 2003). The experiment by Tavi et al, which 
involved pharmacological inhibition of CaMKII, was modelled by removing the 
CaMKII-dependent modifications of RyR from our FT model. Although it was not 
explicitly demonstrated by Tavi et al. (2003), it was assumed that the pharmacological 
inhibition of CaMKII was absolute and specific. The FT values of KmMax and 
DPowermax were subsequently incorporated into the ST model as well, as there is no 
similar experimental evidence available for this muscle type.    
 
 
Figure 1: Schematized calcium model and CaM-CaMKII reaction schemes. 
A: Simplified visualisation of the different spatial elements in the computational model of calcium 
dynamics in a half-sarcomere, adapted from Groenendaal et al. (2008). The model is bordered by 
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a z-line on one side and an m-line on the other side. The grey elements (top row) make up the SR 
and the white elements (bottom tree rows) make up the myoplasm. Note that the actual model is a 
cylinder, and the elements are actually rings, with the lower border of the bottom elements as their 
centre. B: Reaction scheme for sequential binding of calcium to the C-terminal and then the N-
terminal EF-hand of calmodulin. C: Reaction scheme for binding of calcium and calmodulin to 
CaMKII, and conversion of the CaMKII fractions to a phosphorylated state. pThr287 indicates 
that CaMKII is phosphorylated at threonine287. Phosphorylation of CaMKII at threonine 287 in 
the model is reversed by the action of protein phosphatase 1 (PP1). CaMKII fractions in bold have 
100% activity and the CaMKII fractions in normal font have no activity. Both CaM and CaMKII 
reaction schemes were adapted from Saucerman & Bers (2008). Two-way arrows indicate 
reversibility of the reaction. PP1: Protein phosphatase 1. Ca, CaM, Ca2CaM, Ca4CaM, Pi, Pb, 
Pb2, Pt, Pt2 and Pa, but not PP1, can change over time in the model. Values of reaction 
parameters for this reaction scheme can be found in the Appendix.  
 
Assumptions/estimated parameter values 
To the best of our knowledge, the concentration of CaMKII in skeletal muscle is 
unknown. We assumed a concentration of 1 µM, which has previously been used for 
simulations of CaMKII in skeletal muscle fibres (Tavi et al., 2003). CaMKII activity in 
non-stimulated muscle is 10% of maximal Ca
2+
/CaM-stimulated activity (Rose et al., 
2007a). Therefore, the initial concentration of Pa was set to 0.1 µM (see Appendix).  
 Total [CaM] in skeletal muscle has been estimated to be approximately 10-20 
µM (Chiesi and Carafoli, 1983). However, in many cell types, CaM is presumed to be a 
limiting factor for calcium signalling (Persechini and Stemmer, 2002). In 
cardiomyocytes, most (99%) of CaM is buffered (Wu and Bers, 2007) and assumed to 
be unavailable for binding to CaMKII. Assuming similar CaM buffering in skeletal 
muscle, we set the concentration of free CaM to 0.15 µM (1% of total). [PP1] was set so 
CaMKII activity lasted for several tens of seconds after a simulation of 100 RyR 
openings, in agreement with data from chapter 2. In the model, no diffusion of any of 
the CaM or CaMKII fractions takes place. [CaM] and [CaMKII] were equal in all 
myoplasmic elements of the model, and in the FT and ST models.     
 
Simulations were performed with Matlab (The Mathworks, v7.5.0) on an ASUS K53S 
laptop (2.2GHz processor, 8 GB RAM) and the ordinary differential equation (ODE) 
solver 15s was used. Conservation of mass during the simulations was checked. 
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Results 
 
Model validation 
The calcium dynamics model predicts a substantial spatial gradient in [Ca
2+
] in 
sarcomeres during twitch contraction (Groenendaal et al., 2008). We compared spatially 
averaged [Ca
2+
] during a simulated twitch of the FT and ST versions of the model with 
experimental data obtained from electrically stimulated mouse skeletal muscle fibres 
(Baylor and Hollingworth, 2003). The model describes rise time and peak [Ca
2+
] 
amplitude of the twitch calcium peak quite well (Table 1), but the slow second half of 
the decrease in [Ca
2+
] in ST fibres reported by Baylor and Hollingworth (2003) was 
absent in the model. Therefore, our modelled ST relaxation time was shorter than the 
experimentally determined relaxation time (Table 1). Adjusting the RyR opening 
parameters (Appendix) did not improve the modelled [Ca
2+
] decrease time without 
substantial changes in the peak [Ca
2+
]. As we judged the peak [Ca
2+
] to be the most 
important parameter determining CaMKII activation, we considered the model to match 
the experimental data of Baylor & Hollingworth sufficiently well to model [Ca
2+
]-
dependent CaMKII activation. 
 
 
 Baylor and Hollingworth (2003) Model 
Parameter FT (EDL) ST (SOL) FT  ST 
TTP (ms) 2.0 2.5 2.0 2.1 
Peak [Ca
2+
] (µM) 21.7 8.6 20.2 8.9 
HRT (ms) 2.0 4.4 1.7 1.9 
 
Table 1: Comparison of modelled and experimental [Ca2+] during one pulse stimulation 
Experimental measures were carried out on single mouse muscle fibres within small bundles of 
fibres at 28ºC (Baylor and Hollingworth, 2003). Model results were obtained from simulations of 
a single RyR opening. TTP: Time-to-peak [Ca2+] during a twitch. HRT: Half-relaxation time of 
the calcium transient during a twitch. FT: fast-twitch. ST: slow-twitch. EDL: mouse m. extensor 
digitorum longus. SOL: mouse m. soleus.   
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To validate the CaMKII reaction scheme, we first compared modelled Ca
2+
-sensitivity 
of CaMKII autophosphorylation and the effect of phosphatase concentration on this 
relationship to that of an independent experimental dataset (Bradshaw et al., 2003). 
Reagent and ion concentrations, and reaction times described by Bradshaw et al. were 
used for these simulations. The model reproduced the concentration for half-maximal 
activation and steepness of the relationship between [Ca
2+
] and CaMKII 
autophosphorylation quite well (Fig. 2A). Furthermore, we compared the modelled 
relation between [CaM] and CaMKII activity, and between [CaM] and CaMKII 
autophosphorylation, with another independent experimental dataset (Gaertner et al., 
2004). The model properly described the experimentally determined [Ca
2+
] 
concentrations for half-maximal CaMKII activity and the steepness of the curve (Fig. 
2B&C). 
 
 
 
Figure 2: Validation of CaM-CaMKII reaction scheme 
A: Comparison of modelled [Ca2+] - phosphoThr287-CaMKII relation (blue lines) with published 
data (red open circles: 0.5 µM PP1; green circles: 2.5 µM PP1) (Bradshaw et al., 2003).  B: 
Comparison of modelled [CaM] - CaMKII activity relation (blue line) with independent 
experimental data (Gaertner et al., 2004). C: Comparison of modelled [CaM] - CaMKII 
autophosphorylation relation (blue lines) with independent experimental data (Gaertner et al., 
2004). Experimental data points are estimated from graphs in cited papers. PP1: Protein 
phosphatase 1. 
 
 
Simulation of prolonged repeated opening of the RyR (i.e. >100 openings) resulted in a 
maximum autophosphorylated (Pt, Pt2 & Pa) CaMKII fraction of 14% of total CaMKII. 
This is somewhat lower than the experimentally determined maximal autonomous 
activity of 22-23% of maximal CaMKII activity in in situ stimulated rat m. 
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gatrocnemius muscle (Rose et al., 2007a). However, it is in accordance with the 
experimentally supported idea that autonomous CaMKII activity does not exceed a 
ceiling of approximately 20% of maximal activity.  
 
Effect of [Ca
2+
] distribution on CaMKII activation  
We determined maximal total CaMKII activity (defined as the sum of Pb4, Pt2, Pt4 and 
Pa) during simulations of single and repeated RyR openings in the FT and ST model. 
Furthermore, we determined whether there was an effect of RyR opening frequency on 
CaMKII activity, as the frequency of exposure of CaMKII to calcium/calmodulin 
determines the development of CaMKII activity in vitro (De Koninck and Schulman, 
1998). CaMKII activity was determined for each myoplasmic compartment. An 
overview of the range of increase in CaMKII activity in the myoplasmic elements of the 
FT and ST models can be found in Table 2. 
 
 
   FT  ST 
Twitch Tetanus Train Twitch Tetanus Train 
10 Hz  
0 - 6.5% 
0.2 - 59% 3.6 - 84%  
0 - 1.2% 
0.2 - 29% 3.6 - 44% 
100 Hz 0.5 - 95% 1.9 - 81% 0.7 - 64% 2.3 - 58% 
 
Table 2:  Increase in total CaMKII activity during single or repeated RyR openings 
 
 
The range of increase in CaMKII activity in myoplasmic elements of FT and ST models 
from the element with the lowest increase to the element with the highest increase. 
Activity was determined at time points during simulations as indicated in Figures 3, 4 & 
5.  
  
As expected, the highest CaMKII activity after one simulated RyR opening occurred 
near the calcium release site, and no increase in activity occurred in the elements close 
to the m-line (Fig. 3). 
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Figure 3: CaMKII activity during a single RyR opening 
Total simulated CaMKII activity (the sum of Pb4, Pt2, Pt4 and Pa) during a simulated single RyR 
opening in the fast-twitch (FT) and slow-twitch (ST) model (see text for model details). Graphs 
on the left display development of total CaMKII activity over time (in milliseconds) during a 
single RyR opening in the FT and ST model as indicated. Blue lines represent CaMKII activity in 
different myoplasmic compartments. Black inverted triangles indicate the approximate time point 
at which the CaMKII activity gradient was analysed, and visualised in the grids on the right. Note 
that the scale of the y-axis differs in the FT and ST graph. Grids on the right visualise the spatial 
distribution of the maximal increase in total CaMKII activity during a single simulated RyR 
opening. Colours indicate the percentage increase compared to the initial total activity, and the 
scale is indicated above the figure. Grid layout is the same as in Fig. 1A. The locations of the z-
line and m-line of the half-sarcomeric model are indicated by Z and M, respectively. NSR: non-
junctional sarcoplasmic reticulum. JSR: junctional sarcoplasmic reticulum. SERCA: 
sarco/endoplasmic reticulum Ca2+-ATPase. RyR: Ryanodine receptor.   
 
 
We investigated whether the CaMKII activity gradient persisted when repeated RyR 
openings were simulated. After ten RyR openings, the spatial gradient in activity 
increase was stronger than after one RyR opening (Table 2, Fig. 4). However, when 
simulating ten repeated trains of ten RyR openings with one-second intervals between 
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the trains, the spatial distribution of CaMKII activity during the final ten RyR openings 
of the protocol is remarkably similar to that during the first ten openings. The main 
difference between the first and last train is an increase in baseline CaMKII activity of 
the most activated elements after the tenth train (Fig. 5), which is mainly due to the 
increase in fraction Pa, the autonomous CaMKII activity. Nevertheless, in all cases 
CaMKII activation was highest near the calcium release site and higher in the elements 
closest to the z-line than in the elements closest to the m-line (Fig. 3). These data 
suggest that CaMKII activity is highest in the vicinity of the calcium release site during 
muscle contractions.   
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Figure 4: CaMKII activity during repeated RyR openings 
Total simulated CaMKII activity (the sum of Pb4, Pt2, Pt4 and Pa) during a simulation of ten RyR 
openings in the fast-twitch (FT) and slow-twitch (ST) model (see text for model details). Graphs 
on the left display development of total CaMKII activity over time (in milliseconds) during ten 
simulated RyR openings in FT and ST model as indicated, and at a RyR opening frequency of 
100Hz (upper two graphs) or 10Hz (lower two graphs).  Blue lines represent CaMKII activity in 
different myoplasmic compartments. In order to optimise visualisation of the graphs, the scale of 
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the y-axis differs in each graph. Black inverted triangles indicate the approximate time point at 
which the CaMKII activity gradient was analysed, and visualised in the grids on the right. Grids 
on the right visualise the spatial distribution of maximal total CaMKII activation during the 
simulation of ten RyR openings. Colours indicate the percentage increase compared to the initial 
total activity, and the scale is indicated above the figure. Note that colour scale in this figure is of 
larger magnitude compared to Fig. 3. Grid layout is the same as in Fig. 1A. The locations of the z-
line and m-line of the half-sarcomeric model are indicated by Z and M, respectively. NSR: non-
junctional sarcoplasmic reticulum. JSR: junctional sarcoplasmic reticulum. SERCA: 
sarco/endoplasmic reticulum Ca2+-ATPase. RyR: Ryanodine receptor. 
 
 
Models of FT and ST sarcomeres were used to investigate whether CaMKII activation 
differs between these muscle types. CaMKII activation was higher in the FT model 
compared to the ST model after single and repeated RyR openings (Table 2, Fig. 3, 4 & 
5). This is associated with a higher peak [Ca
2+
] amplitude in the FT model (Table 1), 
and in partial agreement with experimental data demonstrating that phospho
Thr287
-
CaMKII levels increase in fast-twitch, but not slow-twitch rat muscle after electrical 
stimulation with 100 electrical pulses in situ (chapter 2).     
 
To investigate whether RyR opening frequency affects CaMKII activation, we 
simulated repeated RyR openings at both 10 Hz and 100 Hz. After ten RyR openings, 
CaMKII activation was substantially higher when RyR opening occurred at 100 Hz 
compared to 10 Hz (Table 2, Fig. 4). However, after ten trains of RyR openings, this 
difference between the frequencies had disappeared in the FT model and was reduced in 
the ST model (Table 2, Fig. 5). This was in agreement with experimental data 
demonstrating no effect of frequency on phospho
Thr287
-CaMKII levels after in situ 
stimulation of rat skeletal muscle with 100 electrical pulses at 10 or 150 Hz (Chapter 2). 
These data suggest that a low frequency of RyR opening results in lower CaMKII 
activation during the initial openings, but that as RyR opening continues, the CaMKII 
activation during low frequency RyR opening eventually matches that during high-
frequency RyR opening, and is not likely to be a factor during repeated muscle 
contractions.  
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Figure 5: CaMKII activity during repeated trains of RyR openings 
Total CaMKII activity (the sum of Pb4, Pt2, Pt4 and Pa) during a simulation of 10 x 10 RyR 
openings in the fast-twitch (FT) and slow-twitch (ST) model (see text for model details). Graphs 
on the left display development of total CaMKII activity over time (in milliseconds) during the 10 
x 10 RyR openings protocol in FT and ST model as indicated, and at a RyR opening frequency of 
100Hz (upper two graphs) or 10Hz (lower two graphs). The interval between each train of ten 
RyR openings was one second. Blue lines represent CaMKII activity in different myoplasmic 
compartments. In order to optimise visualisation of the graphs, the scale of the y-axis differs in 
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each graph. Black inverted triangles indicate the approximate time point at which the CaMKII 
activity gradient was analysed, and visualised in the grids on the right. The decreasing baseline 
CaMKII activity can be attributed to PP1 activity, but is adjusted for when calculating the 
increase in activity in each myoplasmic element. Grids on the right visualise the spatial 
distribution of maximal total CaMKII activation during the final 10 pulses of the simulation 
protocol. Colours indicate the percentage increase compared to the initial total activity, and the 
scale is indicated above the figure. Note that the colour scale in this figure is the same as that in 
Fig. 4, but of a larger magnitude compared to Fig. 3. Grid layout is the same as in Fig. 1A. The 
locations of the z-line and m-line of the half-sarcomeric model are indicated by Z and M, 
respectively. NSR: non-junctional sarcoplasmic reticulum. JSR: junctional sarcoplasmic 
reticulum. SERCA: sarco/endoplasmic reticulum Ca2+-ATPase. RyR: Ryanodine receptor.   
 
 
Effect of CaMKII concentration on calcium dynamics in FT and ST fibres 
We used the model to investigate the effect of increased CaMKII concentration, which 
has been shown to increase relaxation speed in rat skeletal muscle (chapter 3), on 
calcium dynamics. CaMKII concentration was increased 50-fold in each myoplasmic 
element. This increased the local concentrations of total active CaMKII during a 
simulation of a single RyR opening compared to the same simulation with 'normal' 
CaMKII concentration (Fig. 6A/C). This increase occurred mainly in the elements 
closest to the RyR. However, it had no effect on the development of the [Ca
2+
] or 
calcium-bound troponin-C concentration ([Ca
2+
-TropC]) over time in the FT and ST 
model (Fig. 6B/D).  
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Figure 6: The effect of increased CaMKII levels on twitch characteristics 
A/C: Total CaMKII activity (the sum of Pb, Pt, Pt2 and Pa) during a simulation of a single RyR 
opening in the fast-twitch (FT; A) and slow-twitch (ST; C) model in which CaMKII concentration 
is increased. Lines indicate CaMKII activity in different myoplasmic compartments. Blue lines: 
[CaMKII] = 1 µM; Red lines: [CaMKII] = 50 µM. Note that the scales on the y-axes are different. 
B/D: Spatially averaged [Ca2+] (left graphs) and [Ca2+-TropC] (right graphs) during a simulation 
of one RyR opening in the FT (B) and ST (D) model. Blue lines: [CaMKII] = 1 µM; Red lines: 
[CaMKII] = 50 µM. Note that scales on the y-axes are different. 
 
 
 An alternative explanation for the experimentally observed increase in 
relaxation speed is an increase in SERCA expression (chapter 3). When increasing 
maximal SERCA activity in the model by two-fold to reflect increased SERCA protein 
level, [Ca
2+
] and [Ca
2+
-TropC] were reduced during the relaxation phase of the twitch 
(Fig. 7 B/D). These data suggest that the decrease in relaxation time when CaMKII is 
overexpressed in rat skeletal muscle cannot be explained by CaMKII-induced increases 
in SERCA activity, but can be at least partially explained by increased SERCA 
expression levels.  
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Figure 7: The effect of increasing SERCA levels on twitch characteristics 
Spatially averaged [Ca2+] (left graphs) and [Ca2+-TropC] (right graphs) during a simulation of a 
single RyR opening in the fast-twich (FT) and slow-twitch (ST) model. Blue lines: SERCA 
activity = normal; Red lines: SERCA activity = 2 x normal. Note that scales on the y-axes are 
different. 
 
Discussion  
 
Main findings 
We aimed to investigate whether CaMKII might be differentially activated within a 
sarcomere depending on its subsarcolemmal location and whether decreases in twitch 
contraction and relaxation times after CaMKII overexpression can be explained by 
CaMKII-dependent modification of RyR and SERCA. We found that the modelled 
spatial gradient in cytoplasmic [Ca
2+
] results in a two-fold decrease in CaMKII activity 
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between the Ca
2+
 release site (i.e. near the z-line) and the part of the sarcomere close to 
the m-line. This gradient existed during simulations of a single RyR opening and 
simulations of repeated trains of RyR opening (Fig. 3, 4 & 5). Furthermore, simulated 
CaMKII activity increased more in the FT model than in the ST model (Fig. 3, 4 & 5). 
Finally, we found that CaMKII-dependent modulation of RyR and SERCA cannot 
explain CaMKII overexpression-induced decreases in twitch contraction and relaxation 
times (Fig. 6). 
 
Model limitations 
RyR and SERCA are both influenced by a plethora of interacting factors (Zalk et al., 
2007, Vangheluwe et al., 2005), which were not modelled because of the lack of 
quantitative descriptions of their effects. It is unknown whether these factors might 
mediate or influence CaMKII-dependent effects on RyR or SERCA. 
 Direct modification of RyR by a calcium/calmodulin-dependent protein kinase-
dependent phosphorylation has been shown to inhibit RyR opening in isolated SR 
membrane patches of frog skeletal muscle (Wang and Best, 1992). In contrast, 
pharmacological inhibition of CaMKII in single mouse skeletal muscle fibres resulted in 
decreased calcium release during tetanic stimulation (Tavi et al., 2003), which suggests 
the effect of CaMKII on calcium release is stimulatory. We valued the latter study more, 
as the data were obtained from intact fibres with intact SR which may include CaMKII-
RyR interactions which are no longer present in isolated membrane patches. Therefore, 
we modelled a stimulatory effect of CaMKII on RyR. 
 To the best of our knowledge, the exact concentrations of CaM, CaMKII and 
PP1 in skeletal muscle fibres are unknown. PP1 concentration was set based on 
experimental results demonstrating that CaMKII phosphorylation can persist for up to 
two minutes after stimulation of rat skeletal muscle with 100 pulses (chapter 2). The 
effects of CaM concentration on global CaMKII activity in the model indicated that this 
is an important determinant of CaMKII activity (Fig. 8). Although increasing the 
concentration of CaMKII and CaM in the model increased the absolute levels of active 
CaMKII, a spatial gradient in CaMKII activity still existed (see Fig. 6A/C for the effect 
of increased CaMKII concentration).  In addition, increasing the CaM concentration 
two-fold in the model did not affect the conclusion that CaMKII-dependent 
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modification of RyR and SERCA was not sufficient to affect the speed of calcium 
release and re-uptake (Fig. 8).   
 
 
 
Figure 8: Effect of increased calmodulin concentration on CaMKII activity and calcium 
release 
Spatially averaged [active CaMKII] during a simulation of 10 repeated pulses at 100 Hz, and  
spatially averaged [Ca2+] and [Ca2+-TropC] during a simulation of a single RyR opening in the 
fast-twich (FT) and slow-twitch (ST) models. Blue lines: [CaM] = 0.15µM. Red lines: [CaM] = 
0.30 µM. Note that scales on the y-axes are different between graphs for FT and ST models. 
 
 
 The experimentally determined effect of CaMKII overexpression on muscle 
twitch relaxation was derived from muscle force traces (chapter 3). Although our model 
predicted that a CaMKII-dependent increase in SERCA expression (chapter 3) leads to a 
decrease in calcium twitch time, the development of force by cross-bridges was not 
modelled. Therefore, it is unclear to what extend the modelled change in calcium 
dynamics in the model translate into a change in force dynamics. However, as 
differences in calcium dynamics are presumed to underlie the difference in twitch time 
between FT and ST muscle (Schiaffino, 2010), the modelled decrease in calcium twitch 
time is likely to have an effect on muscle force dynamics.  
Implications of modelling results for the function of CaMKII in skeletal muscle  
CaMKII has many substrates and one mechanism to achieve signalling specificity is 
physical targeting of the kinase to its substrates (Bayer and Schulman, 2001). As our 
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model predicted that the spatial gradients in CaMKII activity persist during repeated 
RyR openings, CaMKII substrates in skeletal muscle fibres will be differentially 
regulated by CaMKII, dependent on their subsarcolemmal location (Table 2; Fig. 3, 4, 
& 5). 
 RyR is located at the terminal cisternae of the SR (Inui et al., 1987), whereas 
SERCA is located on the longitudinal SR (Jorgensen et al., 1982). CaMKII is targeted to 
the SR by a non-kinase splice variant of the α-CaMKII isoform, αKAP (Bayer et al., 
1998). αKAP co-localises with SERCA2 to the longitudinal SR in mouse m. soleus 
fibres (Nori et al., 2003), suggesting that CaMKII may be physically targeted to 
SERCA. Furthermore, CaMKII is located at the terminal SR in the vicinity of the RyR 
(Chu et al., 1990). Thus, CaMKII appears to be spatially targeted to these targets. As 
CaMKII activity is highest at the site of RyR, and barely activated at a fraction of the 
elements that contain SERCA, CaMKII-dependent regulation of RyR in muscle fibres 
may be stronger compared to that of SERCA, or the SERCA-associated regulatory 
proteins phospholamban and sarcolipin.     
 Similarly, local CaMKII activation could have implications for CaMKII-
dependent regulation of other substrates. CaMKII was found to both complex with, and 
phosphorylate, glyceraldehyde 3-phosphate dehydrogenase, glycogen phosphorylase, 
glycogen debranching enzyme and creatine kinase in SR-membranes, (Singh et al., 
2004). It is unclear whether this complex is located in the immediate vicinity of RyR, 
where it would be most strongly activated.  
Interestingly, β-CaMKII, including the muscle specific βm isoform, binds to f-
actin in biochemical essays as well as in cultured neuronal cells, an interaction which 
has been shown to be inhibited by Ca
2+
/CaM-binding (Shen et al., 1998, O'Leary et al., 
2006, Sanabria et al., 2009). As our simulations suggest that the actin filaments of 
sarcomeres are located in the region where Ca
2+
/CaM-binding to CaMKII takes place 
(Fig.s 3, 4 & 5), this raises the question whether CaMKII might regulate actin assembly 
or bundling in skeletal muscle. However, CaMKII binding to actin in skeletal muscle 
has not yet been demonstrated, and this could be an interesting area for future research.   
 
Overexpression of CaMKII in rat skeletal muscle increases the speed of twitch 
contraction and relaxation (chapter 3). When we increased the CaMKII concentration in 
the model, the calcium and calcium-bound troponin-C concentration dynamics during a 
104 
 
single RyR opening did not differ from that predicted by the simulation with 'normal' 
CaMKII concentration (Fig. 6). The results of our simulation suggest that CaMKII is 
barely activated during one pulse (Fig. 3), which explains the absence of differences 
between the simulations with different CaMKII concentrations. CaMKII overexpression 
increased SERCA2 expression in rat skeletal muscle (chapter 3). In contrast to only 
increasing [CaMKII], additionally increasing maximal SERCA activity in the model 
caused an earlier decrease in [Ca
2+
] and [Ca
2+
-TropC] (Fig. 7B/D). Therefore, increased 
SERCA expression may partially explain the increased relaxation speed observed in 
CaMKII-overexpressing rat muscles (chapter 3).     
 
Although CaMKII activation was highest near the RyR, increasing [CaMKII] in the 
model did not result in a faster rise in [Ca
2+
] in the model (Fig. 6B/D). This is unlikely 
to be related to insufficient CaMKII activity, as increasing baseline CaMKII activity  by 
50-fold in the model only resulted in an approximate doubling of the peak [Ca
2+
] 
amplitude, but not a decrease in time to peak [Ca
2+
] or [Ca
2+
-TropC] (Fig. 9). More 
likely, the absence of an effect of increased [CaMKII] on [Ca
2+
] rise time is related to 
the fact that the description of RyR in the model and its modification by CaMKII 
(Appendix) lacks the relevant components required to model the physiological effect of 
CaMKII on the RyR.   
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Figure 9: Effect of increased basal CaMKII activity on sarcomeric calcium release 
Spatially averaged [Ca2+] (left graphs) and [Ca2+-TropC] (right graphs) during a simulation of a 
single RyR opening in the fast-twich (FT) and slow-twitch (ST) model. Blue lines:  basal [active 
CaMKII] = 0.1µM. Red lines: basal [active CaMKII] = 5.0µM. Note that scales on the y-axes are 
different. 
 
 
Finally, we argue that the existence of a spatial gradient in CaMKII activity also has 
implications for the use of constitutively active mutants when using 
transgenic/overexpression approaches to investigate the function of CaMKII, as these 
introduce CaMKII activity distributed throughout the entire cell, and may therefore also 
introduce phosphotransfer activity to substrates that would normally not receive this.  
 
Conclusion  
The model is a useful tool to investigate CaMKII signalling towards its targets in 
skeletal muscle sarcomeres when reaction kinetic information regarding their activation 
becomes available. Our modelling of CaMKII activity in skeletal muscle sarcomeres 
and its effects show CaMKII is locally activated, and its spatial activity gradient is 
maintained during repeated stimulation. Therefore, the location of CaMKII in a 
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sarcomere is likely to be of importance for its function and should be considered when 
evaluating potential CaMKII targets for physiological relevance.   
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Appendix: Reaction parameter values 
 
Reaction rate calculations 
Reaction rates for the CaM and CaMKII reaction schemes were calculated as in 
Saucerman &Bers (2008), with the modification of using absolute concentrations of Pi, 
Pb, Pb2, Pt, Pt2 and Pa. Some reactions were excluded as described in the methods 
section. Values of the reaction parameters can be found in the tables below. 
 
Calcium-calmodulin binding 
 
Table 2: Reaction parameters for calcium-calmodulin binding  
 
 
  
Parameter Description Value  Reference 
CaMFreeR Free CaM concentration 0.15 µM (Chiesi and Carafoli, 1983) 
Mg Myoplasmic Mg2+ 
concentration 
1 µM (Jones et al., 2004) 
K Myoplasmic K+ 
concentration 
160 µM (Sejersted and Sjogaard, 
2000) 
Kd02 - 14.546 (Saucerman and Bers, 2008) 
Kd24 - 836.69 (Saucerman and Bers, 2008) 
k20 2 Ca dissociation from 
CaM (C-terminal) 
10 s
-1 
(Saucerman and Bers, 2008) 
k02 2 Ca binding to CaM (C-
terminal) 
k20/Kd02  µM
-2
 s
-1 
(Saucerman and Bers, 2008) 
k42 2 Ca dissociation from 
CaM (N-terminal) 
500  s
-1
 (Saucerman and Bers, 2008) 
k24 2 Ca binding to CaM (N-
terminal) 
k42/Kd24  µM
-2
 s
-1
 (Saucerman and Bers, 2008) 
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CaMKII reactions 
 
 
Table 3: Reaction parameters for the CaMKII reaction scheme  
 
Parameter Description Value (units) Reference 
CaMKIItot Total CaMKII concentration 1  µM or 50  µM - 
PiR Initial inactive CaMKII fraction 0.9 - 
PbR Initial Ca4CaM-bound CaMKII 
fraction 
0 - 
Pb2R Initial Ca2CaM-bound CaMKII 
fraction 
0 - 
PtR Initial Ca4CaM-bound 
pThr287-CaMKII fraction 
0 - 
Pt2R Initial Ca2CaM-bound 
pThr287-CaMKII fraction 
0 - 
PaR Initial unbound pThr287-
CaMKII fraction 
0.1 (Rose et al., 2007a) 
PP1tot Total PP1 concentration 0.1  µM - 
Kbi Ca4CaM dissociation from Pb 0.54 s
-1
 (Gaertner et al., 
2004) 
Kib Ca4CaM binding to Pb  kbi/25.7e-3 µM
-1
s
-1
 (Gaertner et al., 
2004) 
kb2i Ca2CaM dissociation from Pb2 14*kbi s
-1
 (Shifman et al., 
2006) 
kib2 Ca2CaM binding to Pb2 Kbi µM
-1
s
-1
 - 
kb42 2 Ca dissociation from Pb k42/5 s
-1
   (Shifman et al., 
2006) 
kb24  2 Ca binding to Pb2 k24 µM
-2
s
-1
 - 
Kta Ca4CaM dissociation from Pt kbi/1000 s
-1
 (Meyer et al., 1992) 
Kat Ca4CaM binding to Pt kib µM
-1
s
-1
 (Meyer et al., 1992) 
kt2a Ca2CaM dissociation from Pt 14*kta s
-1
 (Shifman et al., 
2006) 
kat2 Ca2CaM binding to Pt kib µM
-1
s
-1
 - 
kt42 2 Ca dissociation from Pt k42/5 s
-1
 - 
kt24 2 Ca binding to Pt2 k24 µM
-2
s
-1
 - 
kPP1 Thr287 dephosphorylation 1.72 s
-1
 (Saucerman and 
Bers, 2008) 
KmPP1 Km for Thr287 
dephosphorylation  
11 µM (Bradshaw et al., 
2003) 
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CaMKII-dependent modification of RyR and SERCA 
FT model 
RyR = ([Ca]JSR - [Ca]MYO) * CaMax * (1-e
(-t/tau1)
)
(Power1-DPowermax)
 * (e
(-t/tau2)
)
Power2 
SERCA = CaPump * [Ca]
2 
/ ([Ca]
2 
/ KdPump
2
) 
ST model 
RyR: as in FT model 
CaMKIIreg = CaMKactive
3
 / (KmCaMK
3
 + CaMKactive
3
) 
SERCA = (Jmax_up * CaMKIIreg + 1) * CaPump * [Ca]
2 
/ ([Ca]
2 
/ KdPump
2
)  
 
Parameter Description Value (units) Reference 
CaMax Maximum RyR activity FT: 6.981*10
5 
ST: 2.9088* 10
5 
- 
- 
Tau1 RyR opening parameter FT: 1.11 
 
ST:1.1 
(Groenendaal et 
al., 2008) 
- 
Tau2 RyR opening parameter FT: 1.4074 
 
ST:1.5 
(Groenendaal et 
al., 2008) 
- 
Power1 RyR opening parameter FT: 5 
 
ST:5.2 
(Groenendaal et 
al., 2008) 
- 
Power2 RyR opening parameter FT: 3 
 
ST:3 
(Groenendaal et 
al., 2008) 
- 
CaPump Maximum SERCA activity FT: 170.2749 
 
ST: 56.7583 
(Groenendaal et 
al., 2008) 
(Groenendaal et 
al., 2008) 
KdPump [Ca
2+
] at which SERCA activity 
is half-maximal 
FT: 1 µM 
 
ST: 1 µM 
(Groenendaal et 
al., 2008) 
(Groenendaal et 
al., 2008) 
CaMKactive Total concentration of active 
CaMKII 
Pb+Pt2+Pt+Pa 
µM 
 
KmCaMK Concentration of active CaMKII 
at which effect on substrates is 
50% of maximum effect 
0.2  µM - 
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Table 4: Parameters related to RyR and SERCA activity and their CaMKII-dependent 
modification 
 
 
  
Jmax_up Maximal % increase in KdPump 70% (Hund and 
Rudy, 2004) 
DPower1max Maximal % increase in Power 1 30% - 
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Summary and general discussion 
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In this chapter, the results of the experiments described in this thesis are summarised 
and suggestions for experiments are made to further elucidate the role of Ca
2+
-
calmodulin-dependent protein kinase II (CaMKII) and calcium-dependent signalling in 
regulating skeletal muscle adaptation.  
 
Summary 
Skeletal muscle is able to adapt its phenotype in response to increased usage, and 
improve its strength and fatigue resistance. Calcium-dependent signalling is presumed 
to increase mitochondrial biogenesis, an important adaptation to improve fatigue-
resistance. CaMKII has been suggested to promote a slow-twitch, high oxidative 
phenotype in skeletal muscle, but its physiological role in muscle adaptation has so far 
not been investigated in vivo. The work described in this thesis aimed to elucidate the 
role of CaMKII in skeletal muscle in vivo. For this purpose, a rat model which allows 
for imposing defined stimulation protocols on skeletal muscle in situ was combined 
with the manipulation of CaMKII signalling by somatic gene transfer and a 
computational model of CaMKII signalling.      
 
In chapter 2, the question was addressed whether CaMKII activation depends on 
recruitment frequency and whether its activity remains after muscle stimulation ceases. 
Adult rat skeletal muscle was stimulated in situ by different stimulation protocols after 
which protein levels of total CaMKII and phospho
Thr287
-CaMKII were measured for the 
βM, δA & δD/γB isoforms at different time points. This study consisted of two 
experiments. In the first experiment, m. soleus (SOL) and m. gastrocnemius medialis 
(GM) were stimulated with 100 electrical impulses at 10 or 150 Hz at their active slack 
length (i.e. a length at which no active force is produced). This protocol increased 
phospho
Thr287
-CaMKII of δA and δD/γB isoforms in red GM, δA isoform in white GM, but 
none of the isoforms in SOL. There was no effect of frequency on the level of 
phospho
Thr287
-CaMKII. A decrease in total βm and δD/γB CaMKII was observed in GMW 
after 150 Hz stimulation. These results suggest that CaMKII is more strongly activated 
in fast-twitch muscle, and that motor neuron firing frequency is not an important factor 
in determining CaMKII activation. 
113 
 
In the second experiment, we sampled GM at rest, after determination of 
optimum length and at 2, 10 or 60 minutes after a two-minute isometric contraction 
protocol at optimum length. The following observations were made: 1) After the 
contractile activity required to determine the optimum length of the muscle, 
phospho
Thr287
-CaMKII for the δA isoform was increased in red GM compared to rest. 2) 
Phospho
Thr287
-CaMKII was higher in white GM compared to red GM regardless of 
stimulation. 3) Total CaMKII decreased over time in white GM. These results suggest 
that after a short contraction protocol, phospho
Thr287
-CaMKII is transiently increased in 
an isoform- and muscle-dependent way. The results of the first and second experiment 
together suggest that CaMKII remains activated for 1 to 15 minutes after stimulation.    
 
In chapter 3, the effects of acute CaMKII overexpression in skeletal muscle in vivo were 
investigated. α/β-CaMKII was overexpressed in adult rat m. gastrocnemius (GM) and m. 
soleus (SOL) by electroporation-mediated gene transfer. We hypothesised that CaMKII 
overexpression would increase the expression of mitochondrial genes. However, our 
experiments showed that CaMKII overexpression did not increase protein levels of 
cytochrome c oxidase IV (COXIV) in GM or SOL. The mRNA levels of oxidative 
phosphorylation components COXIV, COXI and transcriptional co-activator 
peroxisome proliferator-activated receptor gamma co-activator 1α were not different in 
empty- and CaMKII-transfected SOL, whereas succinate dehydrogenase subunit b 
mRNA was decreased in CaMKII-transfected SOL. Force parameters of transfected 
muscles were measured in situ with intact innervations and perfusion. Strength and 
fatigue resistance of control- and CaMKII-transfected SOL and GM did not differ. 
However, we observed that CaMKII overexpression caused a decrease in twitch time-
to-peak force and half-relaxation time. In addition, CaMKII-overexpressing SOL fibres 
displayed increased sarco/endoplasmic reticulum Ca
2+
-ATPase 2 expression compared 
to non-transfected fibres. Our results therefore suggest that increased CaMKII levels 
alone are not sufficient to increase mitochondrial biogenesis, but may be involved in 
calcium handling and the regulation of contractile force characteristics.  
 
In addition to its role in mitochondrial biosynthesis, CaMKII is presumed to be involved 
in the regulation of a signalling pathway that controls skeletal alpha-actin expression. In 
chapter 4, we investigated the effect of CaMKII overexpression on the transcription of 
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skeletal alpha-actin (SKAA). We hypothesised that CaMKII overexpression would 
increase SKAA promoter activity and mRNA levels. The luciferase gene controlled by a 
SKAA promoter fragment was electro-transferred into m. soleus (SOL) and m. 
gastrocnemius (GM) of both legs. CaMKII was overexpressed in SOL and GM of the 
right leg only. In contrast to our hypothesis, luciferase activity measured in protein 
extracts of the CaMKII-transfected muscles SOL and GM was significantly lower 
compared to that in muscles transfected with the reporter only. SKAA mRNA level 
tended to be lower in SOL of the CaMKII transfected leg, but this was not significant. 
We concluded that CaMKII overexpression had a negative effect on SKAA gene 
transcription, but that the mechanisms underlying this effect require further 
investigation.  
 
The results described in chapter 3 demonstrated that CaMKII overexpression in vivo 
decreased twitch contraction and relaxation time. However, it was unclear if direct 
CaMKII-dependent modification of the calcium release and re-uptake channels could 
have contributed to this effect. In chapter 5, we investigated whether CaMKII is 
activated more strongly when it’s located in the vicinity of the RyR, and if increasing 
CaMKII concentration in sarcomeres is sufficient to explain decreased twitch 
contraction and relaxation times following CaMKII overexpression in rat skeletal 
muscle. A mathematical model of spatiotemporal sarcomeric [Ca
2+
] dynamics coupled 
to a biochemical model of CaMKII activation was used. The model predicted substantial 
spatial gradients in CaMKII activity in sarcomeres of fast- and slow-twitch muscle 
fibres during single and repeated RyR openings. Increasing CaMKII concentration in 
the model to mimic CaMKII overexpression did not produce decreased twitch 
contraction and relaxation times as observed in vivo (chapter 3). It was suggested that 
this may be due to the fact that CaMKII is minimally activated during a twitch. As 
CaMKII overexpression was shown to increase SERCA2 expression in m. soleus 
muscle fibres (chapter 3), the effects of increased SERCA levels were also modelled. 
This resulted in a decreased relaxation time in the model. We concluded that a CaMKII 
overexpression-induced increase in SERCA expression, but not modification of 
SERCA, can at least partly explain the observed decrease in twitch contraction and 
relaxation times. 
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Considerations regarding overexpression of wild-type CaMKII by 
electro-assisted gene transfer 
A few technical issues related to the approach used to overexpress CaMKII in rat 
skeletal muscle have not been explicitly addressed in the individual chapters, and will 
be discussed here.   
 
The results of the transfection experiments described in this thesis demonstrate that 
CaMKII overexpression has effects on the expression of SERCA2 protein and skeletal 
alpha-actin promoter activity. This raises the question as to what the mechanisms are via 
which these effects were achieved. It is generally presumed that CaMKII affects cellular 
functions through its kinase activity. Because a wild-type CaMKII was overexpressed, 
the activation of the exogenous CaMKII likely depended on muscle recruitment-induced 
increases in calcium/calmodulin concentration. We attempted to determine whether 
exogenous CaMKII was activated after in situ stimulation of muscle, by comparing 
phospho
Thr287
 levels in stimulated and non-stimulated CaMKII-transfected muscles 
(chapter 3). Although increased phospho
Thr287
 levels of the exogenous β-CaMKII 
isoform was observed in some of these experiments, this was not consistent. It is also 
possible that Ca
2+
/CaM-dependent, rather than Ca
2+
/CaM-independent activity (which is 
reflected by phospho
Thr287
-CaMKII) is increased in CaMKII overexpressing muscles. 
However, as Ca
2+
/CaM-dependent activity cannot be measured, it cannot be concluded 
with certainty that any observed effects of CaMKII overexpression are due to increased 
(contraction-induced) kinase activity. 
 
COXIV was measured as a marker of mitochondrial density, as its expression in skeletal 
muscle is increased by CaMKIV and PGC-1 overexpression (Wu et al., 2002, Jiang et 
al., 2010) , and therefore we hypothesised that COXIV expression would be increased in 
rat skeletal muscle by CaMKII overexpression. An increase in COXIV expression 
would not have demonstrated an increase in functional mitochondria, as these consist of 
many different proteins. However, if mitochondrial volume density had increased, 
COXIV protein levels would have been increased. As we observed no difference in 
COXIV protein level between control- and CaMKII-transfected muscles, we presume 
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that the volume of functional mitochondria was also not increased in CaMKII-
transfected muscles. 
 Electroporation was used to induce uptake of plasmid DNA by the muscle 
fibres. This method is thought to result in the permeabilization of the cell membrane, 
allowing DNA molecules to enter the cytoplasm. Thus, the method depends on the 
induction of some degree of damage to the muscle fibres. To identify the effects of 
CaMKII overexpression, CaMKII-transfected fibres were compared to adjacent non-
transfected fibres. As described in chapter 3, separation of these two fibre populations 
was based on visual inspection of CaMKII immunostaining intensity. Both fibre 
populations contained centrally-nucleated fibres, indicating ongoing regeneration. 
Therefore, it is conceivable that both populations have taken up the plasmid DNA, but 
that the 'non-transfected' fibres expressed the encoded CaMKII at much lower levels. 
This might be an explanation for the absence of a difference in COXIV expression. 
However, we did detect a significant difference in SERCA2 immunostaining intensity 
between transfected and non-transfected muscle fibres. Therefore, it seems likely that 
the difference in CaMKII expression levels achieved between 'CaMKII-transfected’ and 
'non-transfected' fibres is of a sufficient magnitude to expose CaMKII-dependent effects 
on protein expression.  
 
Regulation of CaMKII activity in skeletal muscle 
Although CaMKII is known to be activated during exercise in humans (Rose and 
Hargreaves, 2003), very little is known about the physiological regulation of this 
activity. In this section, we discuss the factors that regulate activation and deactivation 
of CaMKII in skeletal muscle. 
 
CaMKII activation 
A large degree of variation in levels of phospho
Thr287
-CaMKII was observed in resting 
SOL and GM compared to the magnitude of the effect of in situ stimulation on the 
levels of phospho
Thr287
-CaMKII in these muscles as reported in chapter 2. The relatively 
high variation in phospho
Thr287
 could be related to the fact that the muscles were not 
immediately sampled after the contraction protocols. However, this suggestion was not 
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supported by experiments described in chapter 3, whereby transfected muscles were 
freeze-clamped after two minutes of stimulation. In these experiments, no consistent 
increases in phospho
Thr287
 levels of the endogenous CaMKII isoforms were detected 
(Chapter 3, Fig. 2). Combined with the difference in resting levels of phospho
Thr287
-
CaMKII, this demonstrates that other factors than neural stimulation regulate CaMKII 
phosphorylation.  
Passive stretch of mouse EDL and SOL ex vivo (i.e. without intact neural 
stretch reflex loops) increased phospho
Thr287
-CaMKII in these muscles (Jensen et al., 
2007), and may therefore be one such non-neural factor. However, as the muscles in the 
'slack contraction' experiment (chapter 2) were not stretched and a substantial degree of 
variance in phospho
Thr287
-CaMKII levels was still observed, this is unlikely to be one of 
the main factors causing the variance in phospho
Thr287
-CaMKII levels in the muscles in 
our experiments. A possibility is that the calmodulin concentration differs in muscles 
from different animals. As reported in chapter 5, calmodulin concentration may be a 
limiting factor for CaMKII activation, and therefore a higher calmodulin concentration 
may lead to a higher CaMKII activity upon neural stimulation. Intramuscular 
calmodulin concentration doubled within two days of chronic electrostimulation of 
rabbit EDL (Antipenko et al., 1999), suggesting that calmodulin expression is in fact 
regulated by long-term muscle activity pattern. However, this would not explain the 
variation in the resting level of phospho
Thr287
, as the animals used during our 
experiments were not trained and had similar activity patterns as they were kept in cages 
until the measurements were carried out. Therefore, it is still unclear what caused the 
variation in the phospho
Thr287
-CaMKII levels in SOL and GM in our experiments. 
 
The regulation of CaMKII activation may depend on the muscle phenotype. The 
modelling results of chapter 5 suggest that the higher amplitude of fast-twitch (FT) 
calcium transients activate CaMKII to a greater extend in FT muscle compared to slow-
twitch (ST) muscle. This is supported by the experimental data reported in chapter 2, 
which demonstrated that CaMKII autophosphorylation was increased in fast-twitch GM, 
but not in slow-twitch SOL after in situ stimulation with 100 electrical pulses. To the 
best of our knowledge, no other study has investigated electrical stimulation-induced 
CaMKII phoshorylation in different muscle types. Further work is required to determine 
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whether the difference in stimulation-induced phospho
Thr287
-CaMKII levels in FT and 
ST muscles persists during longer stimulation protocols reflecting exercise sessions.  
 In addition to affecting stimulation-induced CaMKII phosphorylation, muscle 
type also has an effect on basal levels of phospho
Thr287
-CaMKII. Increased resting levels 
of phospho
Thr287
-CaMKII levels were observed in skeletal muscle after a period of one-
legged endurance training in humans (Rose et al., 2007b) and after chronic overloading 
of chicken muscle (Fluck et al., 2000b). As these training sessions increased the 
expression of genes involved in regulating oxidative metabolism and muscle size, 
respectively, these results suggest that the increased basal phospho
Thr287
-CaMKII levels 
may be involved in establishing a new muscle phenotype. However, higher levels of 
basal phospho
Thr287
-CaMKII were observed in rat low-oxidative white GM compared to 
high oxidative red GM (chapter 2) and in mouse fast-twitch, low-oxidative EDL muscle 
compared to slow-twitch high-oxidative SOL (Jensen et al., 2007). Therefore, basal 
phospho
Thr287
-CaMKII levels in skeletal muscle is not simply higher as the oxidative 
capacity of the muscle increases, and different mechanisms may regulate resting 
CaMKII phosphorylation in trained and untrained muscle. It is currently unclear what 
the mechanisms are that lead to these increased basal levels of phospho
Thr287
-CaMKII 
levels.  
  
The development of autonomous CaMKII activity is dependent on the frequency of 
exposure of the enzyme to Ca
2+
/CaM (De Koninck and Schulman, 1998). However, we 
observed no effect of neural activation frequency on phospho
Thr287
-CaMKII in 
experiments where muscles at their active slack length were stimulated in situ (chapter 
2). Furthermore, our simulations of CaMKII activity development suggested that the 
RyR opening frequency only has an effect on phospho
Thr287
-CaMKII levels during the 
first few RyR openings (chapter 5). Therefore, the biochemical ‘Ca2+/CaM-frequency 
decoding’ property of CaMKII appears to be relevant in whole muscle only during the 
initial RyR openings. This may be explained by the following three mechanisms: 1) the 
high frequency of calcium release in rat skeletal muscle compared to those used during 
the in vitro experiments by De Koninck & Schulman (13-250 Hz (Hennig and Lomo, 
1985) versus 1-4 Hz (De Koninck and Schulman, 1998)), 2) the relatively slow 
deactivation of phosphorylated CaMKII after muscle stimulation (chapter 2) and 3) the 
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existence of a maximum level of autophosphorylated CaMKII in skeletal muscle 
(chapter 5).  
 
One study has claimed that the frequency at which multiple contractions occur 
determines CaMKII activity. This conclusion was based on mathematical modelling and 
the observation that KN93, a pharmacological inhibitor of CaMK’s, inhibited calcium 
release in single fast-twitch mouse muscle fibres when contractions occurred at 100 ms 
intervals, but not when contractions occurred at 5 second intervals (Aydin et al., 2007). 
However, CaMKII phosphorylation and activity were not measured during this study. 
Therefore, experiments that employ muscle contraction protocols with repeated 
contractions followed by measurement of CaMKII phosphorylation and/or activity are 
still required to confirm whether the frequency of muscle contraction has an effect on 
CaMKII activation.  
 
It cannot be excluded that calcium influx from other sources than the SR is important 
for CaMKII activation. Extracellular calcium can enter the cytoplasm through store-
operated calcium entry (via SR protein stromal interaction molecule 1 and the Orai1 
calcium channel), excitation-coupled calcium entry and transient receptor potential 
channels (TRPC’s) (Dirksen, 2009)). Although calcium influx through TRPC3 has been 
implicated in the activation of the calcineurin - nuclear factor of activated t-cells 
(NFAT) pathway (Rosenberg et al., 2004), very little is known about the magnitude of 
calcium influx through these channels and as of yet no implications for CaMKII 
activation can be derived. 
The calcium concentration in myonuclei also increases during electrical 
stimulation of muscle fibres, but with slower dynamics compared to those in the 
cytoplasm (Liu et al., 2005). CaMKII-like activity has been demonstrated in nuclei 
isolated from chicken skeletal muscle (Fluck et al., 2000a). Some studies have claimed 
that CaMKII in the nucleus is phosphorylated after exercise based on 
immunohistochemical measures (Smith et al., 2008, Liu et al., 2005) but these data are 
not convincing as comparisons of staining intensities between different stained sections 
were made. Therefore, the results are likely to be affected by differences in staining 
quality and imaging settings between the different sections. It is currently unknown 
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which CaMKII isoforms are within the myonucleus, and therefore they cannot be 
distinguished on the western blots performed in chapters 2 and 3.   
The roles of the different CaMKII isoforms and whether they are differentially 
localized in muscle fibres (as for example in cardiac myocytes (Ramirez et al., 1997)) 
requires further investigation. This knowledge will aid in determining which calcium 
micro-domains are important for their activation, and therefore help relate the 
physiological contraction-related stimuli to CaMKII-dependent downstream effects. 
Possibly, this could be done by overexpression of specific CaMKII isoforms, or 
targeting these isoforms for degradation using RNA interference (RNAi). These RNAi 
constructs would likely have to be targeted to the variable region within the association 
domain in order to knock-down individual isoforms (Hudmon and Schulman, 2002). 
 
Oxidation of methionine residues 281/282 gives CaMKII autonomous activity in a 
mechanism parallel to autophosphorylation (Erickson et al., 2008). Like 
autophosphorylation of Thr287, oxidation of Met281/282 requires initial binding of 
Ca
2+
/CaM and prevents blocking of the catalytic domain by the autoinhibitory domain 
(Erickson et al., 2008). Prevention of CaMKII oxidation by overexpression of 
methionine sulfoxide reductase A mitigated aldosterone-induced cardiac rupture in mice 
(He et al., 2011). This suggests that oxidation-dependent CaMKII activity has effects 
separate from those of autophosphorylation-dependent CaMKII activity in the heart. 
The role of oxidized CaMKII has not been the subject of any investigation in skeletal 
muscle. The formation of oxygen radicals is also induced in contracting skeletal muscle 
(Powers and Jackson, 2008), and it would therefore be of interest to determine whether 
oxidation of CaMKII occurs in skeletal muscle.  
 
CaMKII de-activation 
Much like the factors that regulate the activation of CaMKII, the factors that regulate 
the de-activation of CaMKII have received very little attention. Although Ca
2+
/CaM is 
released from CaMKII when the intracellular [Ca
2+
/CaM] is low, phosphorylation of 
CaMKII can only be reversed by the action of phosphatases. In both the ‘two-minute 
isometric contractions’ and ‘slack contraction’ experiments described in chapter 2, 
increased levels of phospho
Thr287
-CaMKII in rat skeletal muscle were increased after 
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very brief stimulation (approximately 100 pulses) and remained up to 15 minutes after 
stimulation of rat skeletal muscle. This suggests that CaMKII autophosphorylation 
enables CaMKII to outlast the Ca
2+
/CaM stimulus in skeletal muscle required for its 
initial activation.   
One study observed increasing CaMKII activity and phospho
Thr287
-CaMKII 
levels  in rat fast-twitch EDL muscle in situ during stimulation up to 3 minutes after 
which both activity and phosphorylation decreased during continued stimulation (Rose 
et al., 2007a). In chapter 2, we reported that although phospho
Thr287
-CaMKII levels for 
the δA-CaMKII isoform were increased after the activity required to determine optimum 
muscle length, phospho
Thr287
-CaMKII was not increased for any of the CaMKII 
isoforms after a further two minute isometric contraction protocol (chapter 2). This 
suggests that muscle stimulation increases CaMKII phosphorylation, but also activates a 
pathway that dephosphorylates CaMKII, so that an elevated level of phospho
Thr287
-
CaMKII is only maintained after brief stimulation, and CaMKII is dephosphorylated 
during prolonged stimulation. The identity of this pathway for CaMKII 
dephosphorylation in skeletal muscle is currently unknown and requires further 
investigation.  
 
CaMKII function in skeletal muscle 
The current view in the literature is that CaMKII is involved in the regulation of 
mitochondrial biogenesis in skeletal muscle. However, our data indicate that basal levels 
of phospho
Thr287
-CaMKII are higher in low-oxidative white compared to high-oxidative 
red rat m. gastrocnemius medialis (chapter 2). This result and the observation that 
CaMKII overexpression did not increase COXIV expression (chapter 3) indicate that 
increased CaMKII autophosphorylation and protein level are not sufficient to increase 
COXIV expression, which is essential to increase mitochondrial capacity. A possibility 
which has not yet been discussed is that CaMKII induced paracrine signalling that 
stimulated COXIV expression in non-transfected fibres as well as CaMKII-
overexpressing fibres in the same muscle. In this case, there would not be a difference in 
COXIV staining intensity on the level of single fibres, but there would be a difference in 
COXIV expression between control- and CaMKII-transfected muscles detected by 
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western blot. However, we observed no difference on COXIV levels between control- 
and CaMKII-transfected muscles on a western blot (Fig. 1). 
 
 
Figure 1: The effect of CaMKII overexpression on COXIV protein levels in whole muscle 
Graphs display COXIV protein levels in control- (CON) and CaMKII-transfected GM (A) and 
SOL (B) as determined by western blotting followed by immunodetection. Bars represent mean 
COXIV and points represent the data obtained from individual samples. Points connected by a 
dashed line represent intra-animal muscle pairs. Significance of the difference between control- 
and CaMKII-transfected muscle s is indicated. Example blots are shown below the graphs. Actin 
was detected by ponceau s staining of the blot and serves as a loading control.  
 
 
CaMKII per se may not be sufficient to induce mitochondrial biogenesis but it might be 
required in combination with other stimuli. This was indirectly suggested by the 
observation that the pharmacological CaMK inhibitor KN93 inhibited calcium-
dependent activation of p38 mitogen-activated protein kinase (MAPK) in mouse 
epitrochlearis muscle ex vivo (Wright et al., 2007). MAPK inhibition had been 
demonstrated in the same study to inhibit calcium-dependent mitochondrial gene 
expression. However, this study did not measure the effect of CaMKII inhibition on 
mitochondrial expression directly. Inhibition of CaMKII in mouse skeletal muscle in 
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vivo has been carried out, but no data on mitochondrial gene expression have been 
reported (Murgia et al., 2009). It is therefore still unclear whether CaMKII is required 
for mitochondrial gene expression in vivo. 
 
In contrast, the data presented in chapters 3 and 4 suggest that CaMKII overexpression 
is sufficient to increase SERCA2 protein expression and decrease skeletal alpha-actin 
promoter activity. This suggests that CaMKII does influence gene expression in skeletal 
muscle. Can putative CaMKII-dependent pathways of gene regulation explain increased 
SERCA2 expression? The SERCA2a promoter contains a serum response element 
(SRE) (Baker et al., 1998), and SRF overexpression resulted in decreased SERCA2 
mRNA levels in cardiomyocytes (Zhang et al., 2001). This suggests that SRF might 
have an inhibitory effect on SERCA2 transcription. As CaMKII phosphorylates SRF at 
sites which either inhibit or stimulate its DNA binding (Fluck et al., 2000a, Rivera et al., 
1993, Wheaton and Riabowol, 2004), our results suggest that CaMKII overexpression 
inhibited SRF DNA binding and decreased the activity of the SRF promoter construct 
(which contains three SREs (chapter 4)). Possibly by the same mechanism, CaMKII 
overexpression increased SERCA2 expression (chapter 3). In addition to SRF, MEF2 
might be a CaMKII-regulated factor which mediates increases in SERCA expression 
(Lu et al., 2000a). A MEF2 site is present on the SERCA promoter, but SERCA 
promoter activity in cardiomyocytes is only increased when MEF2 is co-overexpressed 
with NFAT (Vlasblom et al., 2004), which is not known to be regulated by CaMKII. It 
should be noted that no increase in SERCA mRNA was observed in the CaMKII 
overexpression experiments in chapter 3. In conclusion, our data point to SRF as a 
possible mediator of CaMKII-dependent signalling in skeletal muscle in vivo, but its 
actual involvement still requires experimental verification.  
 
Interestingly, δ-CaMKII expression increases in regenerating muscle (Abraham and 
Shaw, 2006). Increased calcium influx through damaged muscle membranes is thought 
to be an important factor in the pathophysiology of dystrophic muscle, as it may activate 
calcium-dependent proteases such as calpains (Whitehead et al., 2006). Stimulation of 
calcium removal from the cytoplasm by SERCA overexpression mitigates the 
dystrophic phenotype in skeletal muscle of mdx mice (Goonasekera et al., 2011). In the 
electroporated muscles in chapter 3, SERCA2 expression was decreased in the damaged 
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electroporated region compared to the non-electroporated region (Fig. 2). SERCA2 
expression in m.soleus is also decreased during myotoxin-induced regeneration (Zador 
et al., 1996). In contrast, CaMKII overexpression increased SERCA2 protein expression 
(chapter 3, Fig. 6). Furthermore we observed a normalization of twitch contraction and 
relaxation time (chapter 3, Fig. 5). However, no improvements in maximal forceof the 
CaMKII-overexpressing muscles were observed seven days after transfection.  Whether 
CaMKII overexpression decreases resting calcium level or calcium transients during 
muscle stimulation will require experimental verification. CaMKII could be co-
overexpressed with a calcium-sensitive probe which allows for in vivo imaging (Rudolf 
et al., 2004). A comparison can then be made with the contra-lateral muscle 
overexpressing the probe only. To conclude, our results suggest that CaMKII may 
stimulate muscle regeneration by increasing SERCA2 expression. 
 
 
Figure 2: Decreased SERCA2 protein in 
damaged SOL fibres 
Immunofluorescence image of SOL subjected to 
electroporation procedure and stained for 
SERCA2. The left half of the image contains 
small regenerating fibres, whereas the right half of 
the fibres is undamaged.The lower staining 
intensity in the regenerating fibres indicates lower 
SERCA2 levels in these fibres.   
 
 
 
 
The combined results of the stimulation and transfection studies in this thesis suggest 
that CaMKII regulates gene expression in skeletal muscle, but that its muscle 
recruitment-dependent activity is limited to brief periods during and after muscle 
recruitment. The CaMKII activity pattern suggests that it is mostly involved in 
regulating acute processes during muscle contraction, rather than regulating processes 
such as the changes in gene expression during the recovery period after exercise. How 
can this apparent contradiction be explained? Firstly, it is not quite clear what the role of 
basal CaMKII activity in muscle is. As shown in chapter 2, there are differences in basal 
CaMKII phosphorylation between different muscle fibre types, and some studies have 
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demonstrated an increase in basal CaMKII phosphorylation after a period of training 
(Rose et al., 2007b, Fluck et al., 2000b). It may be that changes in basal activity and 
expression are related to adaptation (though not of oxidative capacity), and that 
contraction-induced activity is related to acute functions such as glycogen metabolism 
and calcium release. The latter hypothesis is supported by the modelling results 
described in chapter 5, which show that the increase in CaMKII activity is largest near 
substrates involved in regulating glycogen metabolism and calcium release (Singh et al., 
2004, Leddy et al., 1993). Assessment of the impact of changes in basal CaMKII 
activity on muscle phenotype requires experiments in which skeletal muscles in vivo are 
overexpressing a constitutively active CaMKII-mutant. As of yet such experiments have 
not been carried out, but using the methods described in this thesis will provide relevant 
information regarding the role of CaMKII in skeletal muscle adaptation.  
 
The role of calcium in mitochondrial gene expression 
Calcium influx into skeletal muscle is generally considered to be a factor which 
stimulates mitochondrial biogenesis (Ojuka et al., 2003, Wright et al., 2007, Bruton et 
al., 2010). This raises the question as to what the mechanism is through which the 
calcium-dependent increases in mitochondrial biogenesis are achieved. Constitutively 
active calcineurin increases mitochondrial biogenesis in mouse skeletal muscle (Long et 
al., 2007, Jiang et al., 2010), and thus the effects of increasing calcium concentration 
may be mediated by calcineurin. However, an alternative explanation is that the effects 
of chronically elevated calcium concentration may be caused by indirect effects (i.e. not 
requiring calcium-dependent molecules). Increased cellular energy expenditure is likely 
required because calcium needs to be actively removed from the cytoplasm as 
continuously elevated calcium concentrations are associated with skeletal muscle 
pathology (Oberc and Engel, 1977). The resulting increase in intracellular AMP, and 
decrease in ATP concentration could activate AMPK, which appears to be sufficient to 
increase mitochondrial gene expression (Garcia-Roves et al., 2008). Alternatively, the 
increased calcium levels may have activated CaMK kinase (CaMKK), which activate 
AMPK in skeletal muscle (Jensen et al., 2007). CaMKK can be inhibited by KN93 
(Jensen et al., 2007), and this might therefore explain the observed KN93-dependent 
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attenuation of mitochondrial gene expression in response to calcium (Wright et al., 
2007).  
 
A promising approach to test the physiological role of calcium in muscle adaptation 
without chronically elevating the intracellular calcium concentration is to use 
actomyosin-ATPase inhibitors to separate the calcium influx from muscle contraction 
(Dentel et al., 2005). This experiment cannot be carried out in situ or in vivo, as the 
actomyosin inhibitor would paralyse the diaphragm. Isolated muscles should be 
incubated with or without the inhibitor, and stimulated with a protocol that stimulates 
mitochondrial gene expression. A comparison with unstimulated muscles should 
identify whether physiologically relevant calcium transients can stimulate mitochondrial 
gene expression to the same extend as observed in contracting skeletal muscle. 
 
Conclusion 
The aim of this thesis was to elucidate the role of CaMKII in skeletal muscle adaptation 
in vivo. We conclude that CaMKII is activated by very brief stimulation in a recruitment 
frequency-independent manner, and that increased CaMKII protein levels increase 
SERCA2 expression, but not mitochondrial gene expression. We speculate that 
contraction-induced CaMKII activity may be mainly involved in regulating acute 
processes in skeletal muscle, and that chronic increases in CaMKII activity regulate 
long-term adaptation of skeletal muscle. The adaptations regulated by CaMKII are still 
unclear and deserve further investigation.   
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De regulatie van skeletspieradaptatie: CaMKII als sensor van 
calcium signalen 
 
Skeletspierweefsel heeft als kenmerk dat het de eigen structuur en functie aanpast aan 
de belasting die aan het weefsel wordt opgelegd als gevolg van het menselijk bewegen. 
Hierdoor worden spieren over het algemeen groter en sterker door krachttraining en 
neemt de weerstand tegen spiervermoeidheid toe door duurtraining. De influx van 
calcium in de spiervezels tijdens spiercontracties wordt verondersteld een belangrijk 
signaal te zijn voor de vezels om deze aanpassingen door te voeren. Echter, over de 
precieze rol van de enzymen die door de calcium-influx in spiervezels worden 
geactiveerd is nog veel onbekend. Calcium/calmodulin-dependent protein kinase II 
(CaMKII) is een calcium-afhankelijk enzym dat in de spieren geactiveerd wordt tijdens 
fietstraining, maar hoe deze activiteit gereguleerd wordt door het specifieke spier-
activatiepatroon is onbekend. Verder is CaMKII in gekweekte spiercellen noodzakelijk 
om de transcriptie van genen te activeren die belangrijk zijn voor de mitochondriële 
biosynthese. Deze en andere mogelijke functies van CaMKII in skeletspieren zijn echter 
nog niet onderzocht in vivo, waardoor de relevantie van CaMKII voor 
skeletspieradaptatie als gevolg van training nog onduidelijk is.  
 Het doel van dit proefschrift is om te onderzoeken hoe de activiteit van 
CaMKII wordt gereguleerd door stimulatie van skeletspieren, en welke effecten 
CaMKII heeft op skeletspierstructuur en functie in vivo. Hiervoor wordt een ratmodel 
gebruikt om de volgende redenen: 1) de spieren van de ratten hebben goed 
gedefinieerde eigenschappen en kunnen elektrisch worden gestimuleerd met precies 
gecontroleerde stimulatiepatronen, en 2) CaMKII kan tot overexpressie gebracht 
worden in de spieren van de ratten door middel van gen-electrotransfer, waardoor een 
indruk verkregen kan worden van de specifieke effecten van dit enzym in volgroeide 
spiervezels in vivo. De verwachting was dat CaMKII geactiveerd zou worden op een 
spier- en stimulatiepatroon-afhankelijke wijze, en dat CaMKII overexpressie de 
expressie van mitochondriële markers zou doen toenemen.       
 Hoofdstuk 2 beschrijft hoe het effect van spierstimulatiefrequentie op CaMKII 
fosforylering werd onderzocht. CaMKII fosforylering werd gebruikt als maat voor 
CaMKII activatie. Verder werd het verloop van deze fosforylering na afloop van de 
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spierstimulatie onderzocht. CaMKII fosforylering was toegenomen in fast-twitch m. 
gastrocnemius na een stimulatieprotocol bestaande uit 100 pulsen (equivalent aan één 
korte maximale contractie of een submaximale contractie van tien seconden). Tegen de 
verwachting in was er geen effect van de snelheid waarmee deze pulsen elkaar 
opvolgden. In de slow-twitch m. soleus was de CaMKII fosforylering niet toegenomen 
na stimulatie. Een contractieprotocol bestaande uit 24 maximale contracties resulteerde 
niet in een significante toename van de CaMKII fosforylering in m. gastrocnemius. 
Deze resultaten suggereren dat CaMKII zeer snel wordt geactiveerd tijdens 
spiercontracties, maar dat voortdurende contracties wellicht ook de deactivatie van 
CaMKII in gang zetten, waardoor de CaMKII activiteit niet blijvend is. 
 In hoofdstukken 3 en 4 worden de effecten van in vivo CaMKII overexpressie 
in m. soleus en m. gastrocnemius medialis onderzocht. Hoofdstuk 3 focust op het effect 
van CaMKII overexpressie op de expressie van genen die betrokken zijn bij de 
mitochondriële biosynthese, en de contractiele eigenschappen van de spieren. De 
expressie van verscheidene mitochondriele markers was niet toegenomen in CaMKII-
getransfecteerde spieren. Echter, de relaxatietijd van de CaMKII-getransfecteerde 
spieren was afgenomen, en dit ging gepaard met een toename van de expressie van 
SERCA2, het enzyme dat calcium vanuit het cytoplasma terugpompt in het 
sarcoplasmatisch reticulum. Hoofdstuk 4 beschrijft het effect van CaMKII 
overexpressie op de activiteit van een cruciaal deel van de promoter van het skeletal 
alpha-actin gen. Dit gen codeert voor een belangrijk deel van de contractiele filamenten 
in spiervezels. Deze activiteit was significant lager in CaMKII-getransfecteerde spieren. 
De resultaten beschreven in hoofdstukken 3 en 4 suggereren dat toename van CaMKII 
expressie in vivo niet voldoende is om mitochondriële biosynthese te stimuleren, maar 
dat het wel de expressie van SERCA2 en skeletal alpha-actin beinvloedt. 
 In hoofdstuk 5 wordt een mathematisch model van CaMKII activatie 
beschreven en gebruikt om de activatie van CaMKII op het niveau van een sarcomeer te 
onderzoeken. CaMKII stimuleert mogelijk de flux van calcium in en uit het cytoplasma 
door de calciumkanalen ryanodine receptor en SERCA direct te activeren. Daarom werd 
met het model onderzocht wat het effect van toegenomen CaMKII concentratie is op de 
snelheid waarmee calcium in het cytoplasma wordt vrijgelaten en weer uit het 
cytoplasma wordt verwijderd. De simulaties suggereren dat CaMKII het sterkst wordt 
geactiveerd in de buurt van de calciumkanalen waardoor calcium uit het 
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sarcoplasmatisch reticulum stroomt. Het verhogen van de CaMKII concentratie in het 
model had echter geen effect op de snelheid waarmee calcium het cytoplasma in of uit 
stroomde.    
 De resultaten in dit proefschrift suggereren dat CaMKII wordt geactiveerd na 
een zeer korte periode van spierstimulatie op een wijze die onafhankelijk is van de 
stimulatiefrequentie, en dat een toename van de CaMKII expressie in spiervezels zorgt 
voor een toename van de expressie van SERCA2, maar niet van genen betrokken bij 
mitochondriele biosynthese. Mogelijk is CaMKII alleen in combinatie met andere 
signaalroutes betrokken bij de stimulatie van de mitochondriele biosynthese. Verder 
onderzoek moet daarom onder andere uitwijzen of selectieve inhibitie van CaMKII in 
vivo aanpassingen van skeletspieren aan inspanning voorkomt.  
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